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Summary 
 
A functional immune system has to protect the body from pathogens while 
being tolerant to self-antigens (sAg).  To achieve this goal, developing 
thymocytes are subjected to tolerance mechanisms.  Central tolerance takes 
place within the thymus and removes the bulk of auto-reactive thymocytes by 
either clonal deletion (negative selection) or redirection into a regulatory T cell 
lineage (Treg).  Dendritic cells (DCs) are key players in this process.  They 
acquire and present self-peptide in the context of major histocompatibility 
complexes (MHC) to thymocytes and can either promote survival or apoptosis 
of interacting T cells.  To induce tolerance, sAgs are either expressed in the 
thymus or they have to enter the organ from the blood.   
Thymic DCs can be distinguished and subdivided into distinct subsets 
according to their surface markers as well as by their origin.  Thymus resident 
DCs differentiate locally from a progenitor cell, while homed DCs enter the 
thymus fully differentiated from the blood.   
Here, we show by subjecting live, anesthetized mice to multi-photon intravital 
microscopy (MP IVM) that peptide-pulsed, homed DCs promote stable 
interactions with antigen specific but not non-specific thymocytes.  Our 
observations also suggest a functional sub-specialization between thymus 
resident and homed periphery-derived DCs.  While the latter can deliver 
peripheral sAg to the thymus as their cargo, some resident DCs are 
strategically positioned in the thymus to extend processes across the 
endothelial barrier of capillaries and thus are exposed to circulating sAg within 
blood stream.   
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Zusammenfassung 
 
Ein funktionierendes Immunsystem muss den Körper vor Pathogenen 
schützen und gleichzeitig tolerant gegenüber Selbstantigen (sAg) sein. Um 
dieses Ziel zu erreichen, müssen sich entwickelnde Thymozyten 
Toleranzmechanismen unterziehen. Zentrale Toleranz findet im Thymus statt 
und entfernt den Großteil der autoreaktiven Thymozyten durch klonale 
Deletion (negative Selektion) oder durch das Umleiten von autoreaktiven 
Thymozyten in eine regulierende T Zell Linie. Dentritische Zellen (DZ) sind 
Schlüsselfiguren in diesem Prozess. Sie verschaffen sich Zugang zu 
harmlosem Selbstpeptid und präsentieren dieses den Thymozyten auf 
Haupthistokompatibilitätskomplexmolekülen. Damit fördern sie entweder das 
Überleben der interagierenden Zellen oder induzieren Apoptosis. Für diesen 
Vorgang muss Selbstantigen entweder im Thymus exprimiert werden, oder es 
muss vom Blut in dieses Organ gelangen. 
Thymische DZ kann man sowohl anhand der Expression von spezifischen 
Oberflächenmarkern unterscheiden, wie auch anhand ihres Ursprunges. 
Thymus residente DZ differenzieren lokal von einer Vorläuferzelle, während 
eingewanderte Zellen bereits vollständig differenziert vom Blut in den Thymus 
gelangen.   
Mittels Multiphotonenmikroskopie konnten wir erstmals in anästhesierten 
Mäusen zeigen, daß peptidgeladene, eingewanderte DZ stabile Interaktionen 
mit antigenspezifischen aber nicht mit unspezifischen Thymozyten fördern. 
Wir haben herausgefunden, daß es eine Spezialisierung zwischen thymus-
ansässigen und eingewanderten DZ gibt. Während die Letztgenannten 
peripheres Selbstantigen als ihre Fracht in den Thymus liefern, sind 
ansässige DZ strategisch platziert um die endotheliale Schicht der Blutgefäße 
zu durchbrechen und Zugang zu zirkulierendem Antigen aus dem Blut zu 
erlangen. 
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Introduction 
 
Evolution of the thymus 
 
The immune system is divided into two arms, the innate and the adaptive 
immune system.  The innate immune system equips the body with the ability 
to react promptly to bacterial, fungal, parasitic and / or viral insults.  To do so, 
innate immune cells express a broad range of germline encoded extracellular 
and intracellular receptors that are specific for commonly encountered 
features of bacteria, fungi, parasites and viruses.  Because these receptors 
are germline encoded, innate immunity fails to generate a “tailored” immune 
response without the help of the adaptive immune system.  Cells of the 
adaptive immune system, such as B and T lymphocytes, carry B/T cell 
receptor that were generated by somatic diversification of antigen receptor 
genes during the cells’ development.  The B and T cell repertoire is polyclonal 
and each cell expresses a unique antigen receptor, which leads to a broad 
range of specificities.  Natural killer (NK) cells have also been shown to trigger 
adaptive immune reactions1,2.  The adaptive immune system provides a 
customized immune response and has the unique capacity to generate 
immunological memory.  While the innate immune system reacts with the 
same kinetics to a previously encountered pathogen, the memory formation of 
the adaptive immune system allows for an expedited immune reaction upon 
re-encounter of the same pathogen3.   
The innate arm of the immune system is evolutionarily older than the adaptive 
one as evidenced by the fact that all multi-cellular organisms are equipped 
with an innate immune system4 while only jawed vertebrates (gnathostomes) 
have an adaptive immune system that utilizes T and B cell receptors (TCR, 
BCR), RAG proteins, MHC-I and MHC-II molecules5-7.  Interestingly, lamprey 
and hagfish, the nearest living relatives of the evolutionarily older jawless 
vertebrates (agnathans), also have an adaptive immune system.  However, 
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the diversification process that leads to a broad lymphocyte repertoire in 
agnathans is distinct from the one in gnathostomes8,9.   
The genome of jawed vertebrates has undergone two rounds of at least 
partial duplication, which resulted in the current organization of BCR, TCR 
and MHC loci.  The genes that encode the BCR and TCR are exist in the 
germline in a non-functional state, with the 5’ portion of each gene (which 
encodes the antigen binding domain) arranged as arrays of variable (V), 
diversity (D) and joining (J) gene segments10.  The duplication events 
presumably occurred after the split of gnathostomes and cyclostomes (which 
include agnathans) as lampreys only express a single TCR in lymphocyte-like 
cells due to the lack of additional copies of V- and J-like sequences in their 
genome7.  Their adaptive immune system relies instead on the recombination 
of leucine-rich repeats (LRRs) that form the variable lymphocyte receptors 
(VLRs) of lymphocyte-like cells8,11.  Lampreys have T- and B-like 
lymphocytes, that express type A and type B VLR genes, respectively.  In 
contrast to the adaptive immune system of jawed vertebrates that use RAG 
protein mediated recombination to generate a diverse B and T cell repertoire, 
diversification in lamprey is mediated by the cystidine deaminases 1 and 2 
(CDA1, CDA2).  CDA1 promotes the generation of type A VLRs (TCR-like) 
while CDA2 promotes VLRB gene segment recombination (BCR-like)12,13.  
Until recently, the evolutionary origin of the thymus remained enigmatic.  
However, Boehm and colleagues, in two elegant studies, identified thymus 
like tissue, termed thymoid, in the tips of the gill filament and the neighboring 
secondary lamellae of the agnathan lamprey14,15.  Thymoids were identified in 
lamprey larvae according to the expression of the Foxn1 orthologue Foxn1, as 
well as VLRA genes, CDA1 and the absence of VLRB genes and CDA2.  It is 
of note that the expression of Foxn1 is indispensable for thymus formation in 
gnathostomes16.  Furthermore, non-functional VLRA gene rearrangements 
could only be detected in lymphocyte-like cells from thymoids but not from 
blood indicating that this is the place where T-like lymphocytes develop in 
lampreys15. 
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To date it is believed that the evolution of adaptive immune systems in 
gnathostomes and agnathans occurred independently of each other.  
However, given the striking similarities such as the dependence on 
recombination events to generate diverse lymphocyte receptors, and the 
functional similarity of VLRA and VLRB expressing lymphocytes to T and B 
cells, respectively, as well as the identification of a thymus like structure, this 
idea may be called into question.   
 
Thymic architecture and thymus development 
 
In mammals, the thymus is a multilobular organ that is located anatomically in 
the anterior superior mediastinum, in front of the heart, between the lungs and 
behind the sternum (Fig. 1a).  In humans and mice, the thymus consists of 
two lobes.  It can be subdivided into two distinct anatomical regions:  the outer 
cortex and the inner medulla.  One can find distinct stromal and hematopoietic 
cell types in these compartments.  The cortex consists of T cell progenitors 
and cortical thymic epithelial cells (cTEC), while semi-mature and mature T 
cells as well as the presence of medullary thymic epithelial cells (mTECs) are 
unique to the medulla.  Other cell types, such as macrophages (MΦ) and 
mesenchymal cells can be found in both compartments.  Thymic DCs are 
enriched in the medulla and the cortico-medullary junction (CMJ), while they 
are sparse in the cortex.  The CMJ is the transitional area between cortex and 
medulla.  Other structures such as blood vessels are present in both 
anatomical regions, although, their quality differs.  For instance, large venules 
are predominantly found at the CMJ.  Lastly, the thymus is a well-innervated 
organ; like in other organs, neurons “travel” along the vasculature of blood 
vessels in thymi17 (Fig. 1b). 
The cortex can be further subdivided into the subcapsular area (SCA) and 
bona fide cortex.  To date, the specific features of this area remain 
understudied.  However, it is known that TCRß selection takes place in the 
subcapsular area (SCA, see also section “T cell development”).   
Introduction 
6 
One of the specific features of the CMJ is the occurrence of large blood 
vessels that are sheathed by the perivascular space (PVS).  This is also the 
entry point of progenitor cells that home to the thymus and the point of exit of 
mature, naïve T cells18.   
 
Fig. 1.  Anatomy of the murine thymus.  (a) In mammals, such as mice and humans, 
the thymus is located within the rib cage, directly contacting the heart and the lungs.  
(b) In general, the thymus is composed of the outer cortex and the inner medulla.  
These distinct anatomical regions harbor different, functionally specialized cell types.   
 
In mice and humans, the thymus has its origin in the foregut, which develops 
from the third pharyngeal pouch.  This pouch gives also rise to several other 
organs in the neck and chest, such as the parathyroid glands and the 
thymus19.   
It was believed for a long time that the two different anatomical regions of the 
thymus, the cortex and the medulla, develop from the ectoderm and 
endoderm, respectively.  This concept has been revised by two convincing 
studies that have utilized single cell transplantation and cell lineage tracking 
strategies to identify medullary and cortical thymic epithelial cell (TEC) 
progenitors.  Indeed, one single progenitor cell can give rise to a small, albeit 
complete, thymus consisting of both cortex and medulla.  This finding led to 
the conclusion that cortical and medullary TECs can develop from a single bi-
potent progenitor cell20,21.   
The earliest indication of thymus development in mice can be detected at 
gestation day E10.5 by the appearance of epithelial cells in the endodermal 
layer of the third pouch that express the tight junction molecules claudin-3 
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(Cld3) and Cld422.  Forkhead box N1 (Foxn1) is expressed in the fetal thymus 
anlage one day later on E11.5.  Foxn1 is indispensable for thymus 
development and Foxn1+ cells are committed to become TECs16,23,24.  
Furthermore, specification between thymus and parathyroid glands is 
achieved by the mutually exclusive expression of Foxn1 (for thymus) and 
Gcm2 (for parathyroid)23.   
The early E11.5 thymus anlage consists of homogenous TEC progenitors and 
is encapsulated by neural crest (NC) derived mesenchymal cells.  At the 
beginning of vascularization of the thymus at E14.5, NC derived cells can also 
be found sheathing the vasculature as they eventually differentiate into 
perivascular cells or pericytes.  NC derived cells are crucial during early 
thymopoeisis, which is highlighted by delayed and impaired thymus function in 
their absence25-28.  Recently, perivascular cells have been identified as an 
important source of sphingosine-1-phosphate (S1P) and have therefore been 
implied in the S1P dependent emigration of naïve, mature T cells from the 
post-natal mouse thymus into the blood stream18.   
It is noteworthy that seeding of the thymus anlage occurs before 
vascularization.  Fetal liver derived lymphoid progenitor cells are recruited to 
the adjacent primodorum as early as E11.5 and can be found in the fetal 
thymus on E12.529.  The presence of hematopoietic cells in the thymus 
coincides with the onset of cortex / medulla differentiation.  This is not 
surprising given the reciprocal interplay between thymocytes and thymic 
stroma, also termed thymic crosstalk.  Lymphopenic thymi fail to develop and 
/ or maintain normal cortical and medullary structures further highlighting the 
importance of hematopoietic cells in the thymus.  Positively selected 
thymocytes play an essential role in the formation and maintenance of 
medullas and Aire expressing mTECs via RANK/RANKL signaling30,31.  Other 
candidates for thymic crosstalk are Notch1 and its ligands Delta-like 1 (Dll1) 
and Dll4 that are expressed by TECs.  While the role for Notch1-Dll1 and 
Notch1-Dll4 signaling in T cell development has been well established (see 
also section “T cell development”), potential effects on TEC development 
remain unclear.   
Introduction 
8 
It has been shown that a single TEC precursor can give rise to mTECs and 
cTECs.  Experiments involving reaggregated fetal thymic organ cultures 
(RTOCs) that were grafted into T cell sufficient recipient mice further provided 
important insights in cortex and medulla formation.  Briefly, the generation of 
RTOCs relies on the reaggregation of previously enzymatically generated 
single cell suspensions of thymic stroma cells.  Using this technique, it was 
shown that medullas arise clonally while the cortex appears to be polyclonal32.  
Furthermore, it was shown that mTECs in the adult thymus are actively 
proliferating and develop from the EpCAM+ Cld3low4low UEA-1– mTEC 
precursor that gives rise to semi-mature EpCAM+ Cytokeratin5+ MTS10+ UEA-
1+ CD80low86low Aire– mTECs that eventually mature to EpCAM+ Cytokeratin5+ 
MTS10+ UEA-1+ Cld3+4+ CD80high86high Aire+ mTECs22,33,34.  This discovery 
demonstrated that mTECs develop via a progressive maturation rather than a 
parallel development of several mTEC lineages.   
With the initiation of the development of the thymus, its journey from the third 
pharyngeal pouch to its final location within the ribcage begins.  On E12.5, the 
thymus anlage and the parathyroid grow into two distinct domains and finally 
separate from the third pouch and from each other by E13.5.  Although 
physically separated, they still migrate together to their final destination within 
the body.  Thus, the thymus “detours” by taking the parathyroid route19.  
Interestingly, the location of so-called cervical thymi coincides with this route, 
suggesting these ectopic thymi may result from TEC progenitors that have 
dissociated from the thymus anlage on route.  The number and location of 
cervical thymi in mice and humans is not conserved, indicating that their 
generation is not strictly regulated35,36.   
With its arrival in the rib cage, directly above the heart, the thymus has found 
its final destination (Fig. 1a).  The murine thymus reaches its peak cellularity 
at about four to six weeks of age.  After that, it starts to involute and thymic T 
cell output gradually decreases.  In humans, thymus involution starts at 
birth37.  Thymic involution is accompanied by an overall decline in cell 
numbers.  cTEC numbers are especially reduced in involuting thymi, leading 
to a relative enrichment of mTECs and medullary regions and the fusion of 
monoclonal medullas.  Furthermore, thymic involution is accompanied by the 
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accumulation of fatty tissue in the perivascular space and thus expands this 
region within the thymus.  Even though thymic output is reduced, 
thymopoeisis still persists in the elderly38.   
 
T cell development 
 
T cell precursors in the thymus do not have long term self-renewing capacity 
under physiological conditions39 and consequently T cell output relies on the 
replenishment of T cell precursors40.  This is achieved by the periodic 
recruitment of common lymphoid precursors (CLPs) from the BM via the 
blood.  Thus, T cell development starts with the entry of these cells into the 
thymus at the CMJ.  There are different subsets of CLPs that can home to the 
thymus and give rise to T cells.  Interestingly, CLP-2 but not CLP-1 cells are 
equipped with the appropriate homing molecules to access the thymus.41  
Homing of CLP-2 cells follows a classical multi-step adhesion cascade that 
consists of tethering, rolling, integrin activation followed by sticking / firm 
arrest and finally diapedesis.  Rolling is mediated by PSGL-1 – P-selectin and 
VLA4 (α4β1) – VCAM-1 interactions. Gαi mediated activation of VLA4 and 
LFA-1 (αLβ2) leads to firm interaction with VCAM-1 and ICAM-1, respectively, 
and arrest.  This activation is dependent on the CCR9 – CCL25 (TECK) 
receptor – ligand pair41 (Fig. 2).  The last step of the homing cascade, the 
extravasation from the venules into the thymus has not yet been described.   
 
Fig. 2.  CLP-2 cells home to the thymus by employing a multi-step adhesion 
cascade.  Rolling is mediated by PSGL-1 – P-selectin and VLA4 – VCAM-1 
interactions.  Signaling of the receptor – ligand pair CCR9 – CCL25 through Gαi 
triggers activation of LFA-1 and VLA-4 integrins and thus promote firm arrest41.   
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The most immature T cell precursors in the thymus express low levels of CD4 
and lack surface expression of CD842.  They are generally referred to as 
double negative thymocytes (DN).  They can be further subdivided into DN1-3 
and DN4 / pre-double positive (DP) cells.  The most immature DN1 cell is 
characterized by the expression of the stem cell factor receptor c-Kit (CD117) 
and CD44.  They can be found in the cortex, in proximity to venules at the 
CMJ, from which they presumably have entered the thymus.  Upon entering 
the organ in periodic waves, DN1 cells proliferate and are released 
asynchronously to replenish continuously the intrathymic T cell pool and to 
advance to DN2 cells40.   
DN2 cells upregulate CD25 but lose the low expression of CD4 and thus are 
CD4–8–25+44+117+.  They migrate towards the capsule and are found deep 
within the cortex.  This migration has been shown to be mediated by the 
expression of CXCL12 by scattered cortical stromal cells and the 
corresponding chemokine receptor CXCR4 on the thymocytes as well as the 
CCR9 – CCL25 receptor – ligand-pair.  DN2, as well as more committed DN3 
cells, anchor to thymic epithelial cells during migration by utilizing the 
homotypic adhesion molecule E-cadherin as well as VLA4 – VCAM-1 
interactions.  DN2 cells express Notch1, which causes their T lineage 
specification, although they still maintain the potential to give rise to other 
cells types such as DCs and NK cells.  During the migration through the 
cortex towards the capsule, Notch1-expressing DN2 and DN3 cells are in 
close contact with epithelial cells, which express the Notch ligands Dll1 and 
Dll4.  Constant signaling through Notch is essential to maintain T cell lineage 
commitment and deletion of Notch converts pro-T cells to intrathymic B cells 
and DCs43.  DN2 cells also up-regulate Rag genes and rearrange TCRγ and 
TCRδ but not TCRβ or TCRα gene segments.   
DN cells that have reached the capsule have down-regulated CD44 and thus 
are characterized as CD4–8–25+44–117– DN3 cells.  DN3 cells proliferate 
actively and expand approximately fourfold.  They continue to express Notch 
and have greatly diminished potential to differentiate into cell types other than 
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T cells.  Furthermore, RAG proteins are expressed and the TCRβ locus is 
accessible for RAG mediated gene recombination.  Almost all DN3 cells carry 
at least one fully rearranged TCRβ allele.  In-frame rearrangements promote 
survival and allow the cells to advance to the β-selection checkpoint.  This 
process requires the surface expression and association of the TCRβ chain 
with an invariant TCRα chain to form the pre-TCR44,45.  Only if the pre-TCR 
allows for signaling, DN3 cells receive a survival signal and undergo a 
proliferative boost that goes in hand with the advance to DN4 / pre CD4+8+ 
double positive (DP)46,47.   
Post β-selection DN4 / pre-DP cells are characterized by the downregulation 
of CD25 and the partial up-regulation of CD4, CD8 and CD27.  They can be 
identified by the following surface marker profile:  CD4low8low25–27+44–117–.  
Pre-DP and CD4+8+ DP cells leave the sub-capsular area and migrate 
randomly in the cortex48.  The cues that promote the migration away from the 
capsule are poorly understood.  Cortical DP cells express RAG proteins and 
rearrange the TCRα locus.  The rearranged TCRα chain is paired with the 
TCRβ chain and subjected to positive selection.  During this process TCR 
specificities are selected that can interact with self-peptide presented on 
MHC-I or MHC-II of cTECs.  Interaction promotes survival, while failure to do 
so leads to “death by neglect”.  Positive selection enriches for a self-restricted 
T cell pool.  However, by doing so, it also enriches for autoreactive T cells.  
Hence, further quality control steps are required to remove potentially 
dangerous, autoreactive thymocytes.  It is noteworthy that positive selection is 
very wasteful as it removes over 90% of the generated T cells.   
Positive selection does not only select for thymocytes that can interact with 
self-MHC, it also determines CD4 versus CD8 lineage commitment.  Several 
studies have focused on the identification of factors that contribute to either 
lineage decision.  Work to date supports a “duration-of-signal” instructional 
model, in which persistent TCR signaling leads to the expression of the 
transcription factors GATA3 and ThPOK and the development of CD4 SP 
cells, while intermittent TCR signaling in combination with IL-7 activates 
Runx3, a ThPOK silencer that further promotes CD8 lineage commitment49-52.   
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Therefore cells that have passed positive selection are committed to either 
CD4+ or CD8+ T cells and downregulate CD8 or CD4 respectively, resulting in 
a CD4+8– or CD4–8+ semi-mature single positive T cell (SP).  Semi-mature SP 
cells also co-express CD24 (HSA, heat stable antigen), CD69 and low levels 
of L-selectin (CD62L) as well as CCR7.  The CCR7 ligands CCL21 and 
CCL19 are present in the thymic medulla and responsible for the migration of 
positively selected thymocytes from the cortex to the CMJ and medulla48,53.  It 
is noteworthy that positively selected T cells can also undergo negative 
selection in the cortex with no involvement of the medulla under the premise 
that they already express a fully functional TCR and that the selecting peptide 
is presented in this anatomical region of the thymus (e.g. to ubiquitously 
expressed antigens (Ag))54.  However, because of the limited availability of 
self-peptide that is required for the induction of tolerance to a wide spectrum 
of sAgs in the cortex, failure of polyclonal thymocytes to migrate into the 
medulla results in incomplete tolerance induction and autoimmunity18,55.  It is 
also of note that the available peptide repertoire for positive and negative 
selection differs (see also section “Thymic antigen presenting cells in positive 
and negative selection”).   
Semi-mature SP T cells in the CMJ and the medulla are subjected to central 
tolerance.  This process either removes auto-reactive T cells (negative 
selection) or redirects them into a regulatory T cell lineage.  To do so, the 
affinity of the TCR of developing thymocytes with self-peptide that is present 
on MHC-I and MHC-II molecules is tested.  In contrast to positive selection, 
weak interactions promote survival while high affinity interactions induce 
apoptosis.  Interactions with intermediate affinity drive SP T cells, especially 
CD4+ SP cells, into a regulatory T cell lineage and induce expression of the 
IL-2Rα chain (CD25) and Foxp356.  Post-selection thymocytes mature into 
CD4+ or CD8+ SP S1P1+ CD62L+69– mature, naïve thymocytes that no longer 
can be subjected to negative selection.  Instead, the engagement of the TCR 
on these cells triggers clonal proliferation57.  Mature thymocytes also express 
KLF2 (Kruppel like factor 2), a transactivator of the sphingosine-1-phosphate 
receptor 1 (S1P1) promoter, the expression of which is critical for thymocyte 
egress into the blood58.  Emigrating T cells first enter the perivascular space 
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and then reverse transmigrate into the blood18.  Administration of IL-7 has 
been shown to promote thymocyte egress as well59.  However, because 
thymocytes in IL-7R deficient mice did not show an egress defect60, the role of 
IL-7 and its receptor in egress from the thymus remains puzzling.  αβ T cells 
leave the thymus four – five days after becoming SP thymocytes61 (see Table 
1 and Fig. 3 for a schematic overview of T cell development in the thymus).   
 
Table 1.  T cell development 
T cell 
precursor  Phenotype 
Migration direction  
(* denotes predominant 
localization) 
Developmental events 
CLP-2 
lin–           CD127+       Thy-1– 
Sca-1low    c-Kit–          B220+ 
CD19– 
Blood 
↓ 
CMJ* 
↓ 
Thymic stroma / cortex 
•  Homing from the circulation to the  
    thymus in waves 
DN1 CD4
low     CD8–          CD25–    
CD44+     CD117+ 
CMJ 
↓ 
Cortex* 
↓ 
SCA 
•  Proliferation 
•  Desynchronization of T cell 
    development 
DN2 
CD4–       CD8–          CD25+    
CD44+     CD117+      CCR9+  
CXCR4+ 
CMJ 
↓ 
Cortex* 
↓ 
SCA 
•  T lineage specification 
•  TCR αβ versus γδ lineage  
    commitment 
•  TCRγ and TCRδ rearrangement 
•  Proliferation 
DN3 
CD4–       CD8–         CD25+    
CD44–     CD117–     CCR9+  
CXCR4+ 
Cortex 
↓ 
SCA* 
↓ 
Cortex 
•  T lineage specification 
•  TCR αβ versus γδ lineage  
    commitment 
•  TCRβ rearrangement 
•  β selection 
•  Proliferation 
DN4 / pre-DP CD4
low     CD8low      CD25–    
CD27+     CD44–      CD117– 
SCA 
↓ 
Cortex* 
↓ 
CMJ 
•  Proliferation 
•  TCRα rearrangement 
•  Positive selection 
•  CD4 / CD8 lineage commitment 
DP CD4
+       CD8+        CD25–    
CD27+     CD44–      CD117– 
Cortex 
↓ 
CMJ* 
•  Negative selection / Treg  
    induction 
Semi-mature 
SP 
CD4+ CD8–   or   CD4– CD8+ 
CD24+     CD62Llow   CD69+ 
CCR7+ 
Medulla* •  Negative selection / Treg     induction 
Mature SP 
CD4+ CD8–   or   CD4– CD8+ 
CD24–     CD62L+     CD69–  
S1P1+       KLF2+ 
Medulla* 
↓ 
PVS* 
↓ 
Circulation* 
•  Maturation 
•  Thymic egress 
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Fig. 3.  Schematic overview of T cell development in the thymus.  T cell 
development starts with the homing of CLPs to the thymus at the CMJ.  Next, they 
migrate towards the capsule and differentiate into DN thymocytes and rearrange 
the TCRβ chain.  After passing β-selection, the migration direction is reversed and 
the now DP thymocytes migrate towards the medulla.  On route, they rearrange 
their TCRα chain and are subjected to positive selection in the cortex.  Positively 
selected DP cells maturate into SP semi-mature T cells and enter the medulla, 
where negative selection takes place.  Cells that have passed negative selection 
advance to mature, naïve T cells and finally emigrate from the thymus into the 
blood at the CMJ. 
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Thymic antigen presenting cells in positive and negative 
selection 
 
The thymic microenvironment is geared to support T cell development and 
selection.  T cell selection is a process that requires the presentation of self-
peptide in the context of MHC molecules to developing thymocytes.  During 
positive selection, this process promotes survival while during negative 
selection the outcome is reversed.  The profound differences in the 
consequences of TCR engagement have been attributed to several factors.  
Positive and negative selection take place in different anatomical regions of 
the thymus, the cortex and the medulla, respectively.  The cortex provides a 
more nourishing environment than the medulla, which is at least partially 
attributed to the higher density of IL-7 expressing cells60,62.  The T cells that 
are subjected to positive versus negative selection also differ in their 
developmental stage.  Thymocytes that are undergoing positive selection are 
more immature than T cells that are facing negative selection.  Depending on 
their developmental stage, TCR signaling is translated differentially.  Because 
of the spatial separation, the microenvironment and consequently the type of 
interacting antigen presenting cells (APCs) vary as well.  For instance, 
positive selection relies on presentation of Ag by cTECs while negative 
selection is mediated by mTECs and medullary DCs as APCs.  Each of these 
cell types employ a unique mechanism to acquire a broad range of sAg for 
presentation on MHC complexes and T cell selection.  In light of these 
differences, the previously dismissed idea that positive and negative selection 
rely on different peptide pools has recently regained its popularity63,64.   
 
Cortical thymic epithelial cells 
cTEC are indispensable for positive selection and are exclusively found in the 
cortex.  They have unique antigen processing properties as evidenced by 
their expression of the ß5t subunit as part of the proteasome.  The 
proteasome is the major catalytic force generating peptides from 
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cytoplasmatic proteins for presentation on MHC-I molecules.  The expression 
of the ß5t subunit in cTECs is evolutionarily conserved among jawed 
vertebrates that have a thymus that supports T cell development65.  It has 
been shown that expression of this subunit in the thymus imprints its specific 
cleavage site signature on the generated peptide repertoire and that the ß5t 
subunit is indispensable for proper positive selection of cells that eventually 
will give rise to CD8 SP T cells.  Positively selected thymocytes migrate into 
the medulla where they encounter mTECs and DCs as the main APCs 
involved in negative selection.  mTECs and DCs express the ß5i but not ß5t 
subunit of the proteasome.  Thus the proteasome-derived self-peptides in 
cortex and medulla carry the distinct signatures of the ß5t and ß5i subunit, 
respectively, and the peptide repertoire presented is thus likely to be different.  
Deletion of the cortex specific ß5t subunit leads to the expression of the ß5i 
subunit in the cortex, resulting in a similar proteasome-derived self-peptide 
repertoire in cortex and medulla.  In this case, the very same peptides that 
promote survival upon interaction in the cortex during positive selection are 
also generated and presented during negative selection in the medulla.  
However, the outcome is here markedly different and TCR engagement 
during negative selection results in clonal deletion or Treg induction.  Thus, 
positively selected TCR specificities are more likely to be removed during 
negative selection when the peptide pools in medulla and cortex overlap.  In 
consequence the deletion of the ß5t subunit leads to a less diverse CD8 T cell 
pool64.   
Cathepsin L has a similar expression pattern to that of the ß5t subunit.  
Cathepsins are lysosomal proteases that play a role in the degradation of the 
invariant chain (Ii) which otherwise protects MHC-II from premature peptide 
loading.  Cathepsins also proteolytically cleave substrates in the lysosome 
and generate self-peptides for loading and presentation on MHC-II.  
Therefore, cathepsins play an important role in the selection of MHC-II 
restricted CD4 T cells.  Cathepsin L is preferentially expressed on cTECs 
while cathepsin S is abundantly found on mTECs and DCs.  Similar to 
deletion of ß5t, deletion of cathepsin L leads to a greatly reduced T cell 
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repertoire, which in this case is manifested by a reduced number and diversity 
of CD4 T cells66.   
Lastly, cTECs are also distinct from medullary APCs in that they show 
constitutively high levels of macroautophagy.  Macroautophagy is a cellular 
process by which long-lived cellular structures, such as mitochondria and 
parts of the nucleus, are engulfed into autophagosomes that eventually fuse 
with lysosomes and lead to degradation of the contents. In most tissues, such 
as muscle, macroautophagy is induced upon food depreviation and acts as a 
rapid starvation response.  Notably, it is constitutively low / off in brain and 
constitutively on in cTECs in the thymus. As autophagosomes fuse with 
lysosomes they intersect with the MHC-II loading pathway.  Indeed, it was 
shown that macroautophagy contributes to the generation of self-peptides for 
presentation by cTECs in the course of positive selection67,68.   
 
Medullary thymic epithelial cells 
The key players for negative selection are mTECs and DCs.  mTECs have 
gained particular attention in the last decade as they have been shown to 
ectopically express genes that were previously believed to be strictly 
restricted to other tissues.  This process has been termed promiscuous gene 
expression (PGE) and has been shown to at least partially rely on the 
transcriptional regulator Aire69,70.  Aire expression is highest in mature, MHC-
IIhigh CD80high CD86high mTECs, although it can also be detected in immature 
MHC-IIlow CD80low CD86low mTECs and thymic DCs, albeit at low levels.  Even 
though DCs express Aire, PGE has not been detected in these cells.  Failure 
to express Aire in mTECs or mutations in the Aire gene locus lead to 
abrogated PGE, which is manifested in severe autoimmunity such as 
autoimmune polyendocrinopthy-candidiases-ectodermaldystrophy (APECED) 
in humans and mice71.  The current belief is that PGE provides an important 
Ag source to induce tolerance of reactive T cells in the course of negative 
selection.  In order to generate peptides for presentation on MHC-I, the 
proteasome, using the ß5i subunit, and cathepsin S degrade gene products.  
How exactly PGE intersects with MHC-II loading pathways is still not entirely 
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understood.  Macroautophagy is less pronounced in mTECs as compared to 
cTECs; however, it is constitutively on in mTECs, in particular in mature 
mTECs, albeit at low levels.  Indeed it has been suggested that mTECs also 
employ macroautophagy to process self-Ag to make it available for loading on 
MHC-II67.   
mTECs, especially mature mTECs, like DCs express the necessary 
molecules for peptide presentation and promotion of negative selection and 
central tolerance.  However, the role of this cell type in central tolerance is 
somewhat puzzling.  For instance, it was suggested that mTECs are 
specialized in inducing regulatory T cells rather than promoting apoptosis in T 
cells upon TCR triggering72.  This finding was challenged by an in vitro study 
that has shown that other cell types can also induce Treg development of 
thymocytes.  These data are indicative that the sum of quality of signal one 
(TCR affinity) and signal two (co-stimulation) of mTECs is lesser as compared 
to professional APCs, such as DCs.  In this case, the same T cell would be 
directed into a Treg lineage upon interacting with peptide presented on MHC-
II by mTECs, while it would undergo apoptosis upon interacting with the same 
peptide presented by DCs73.  Given that Ag presentation by mTECs appears 
to be inefficient, one wonders whether the main purpose of mTECs is the 
generation and distribution of Ag rather than presenting promiscuously 
expressed genes per se.  Indeed, it was shown that there is a uni-directional 
flow of Ag and MHC molecules from mTECs to thymic DCs74,75.  Furthermore, 
both, mTECs and DCs express connexin34 (Cnx43), a protein that is usually 
found in gap junctions.  Connexins assemble into hemichannels (or 
connexons) at the surface of a cell.  If connexons of two neighboring cells line 
up and interact, they can form a small channel, referred to as a gap junction.  
Ag transfer between DCs is mediated at least in part by gap junctions and 
DCs can access intracellular Ag from apoptotic cells via gap junctions as 
well76,77.  Although formal proof is lacking, it is tempting to speculate that DCs 
can take advantage of the same mechanism to acquire promiscuously 
expressed Ag from mTECs.  Thus, it has been suggested that one of the main 
functions of mTECs is to generate a broad range of self-Ag and to make it 
available to DCs for presentation in order to induce central tolerance78.   
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Thymic dendritic cells 
Thymic DCs have been identified early on as being indispensable for negative 
selection79.  Phenotypically they have been characterized by the expression 
of CD11c and MHC-II.  cDCs in the thymus can be further subdivided into 
CD8α+CD11b– and CD8α–11b+ DC subsets.  Interestingly, the majority of 
thymic DCs are pDCs which represent 30-50% of the thymic DC population.  
The bulk of thymic DCs is believed to develop in situ from progenitor cells80.  
It has been shown that up to 30% of pDCs and CD8α+ DCs carry IgH 
rearrangements of the TCRα chain, indicating that they have developed from 
DN2/DN3 cells81 (Fig. 4).  Indeed, CLP as well DN1-3 cells can give rise to 
thymic DCs, though with decreasing efficiency43.  The accumulation of thymic 
DCs in the medulla, especially of CD11c+11b– DCs is at least in part regulated 
by the expression of XCL1 by mature MHC-IIhigh mTECs and XCR1 by the 
DCs82.  It has also been shown that fully differentiated, yet immature DCs 
have the capacity to home to the thymus (see also section “Dendritic cell 
trafficking to the thymus”).  Upon entering the thymus, they upregulate 
maturation associated markers such as MHC-II and CD8080.  They localize 
almost exclusively in the medulla with a slight enrichment at the CMJ83.  
Homing of DCs to the thymus has been shown to be an important tool to 
deliver peripheral Ag to the thymus and to make it available for negative 
selection83,84 (see also section “Thymic antigen presenting cells in positive 
and negative selection”).  Thymic DCs still maintain the capacity do proliferate 
and may undergo one or two cell divisions upon entering the organ80.  It is 
possible that this is a mechanism to prolong the persistence of Ag similarly to 
cycling splenic DCs whose daughter cells continue to present captured Ag85.  
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Fig. 4.  Schematic of thymic DCs 
and their precursors.  Thymus 
resident DCs can arise locally 
form CLP that home to the 
thymus, DN1, DN2 and DN3 
cells.  In contrast, homed DCs 
enter fully differentiated into the 
organ from the blood.   
 
 
Lastly, small peptide-like antigenic material can also enter the thymus directly 
from the blood and get presented by thymic DCs.  Elegant pioneer work from 
Raviola et al. has helped describing the so-called blood-thymus barrier.  The 
authors established the size cut-off for the thymus-blood barrier to be around 
12 kDa by intravenous injection of proteins with molecular weights ranging 
from 12 – 462 kDa in combination with electron microscopy.  Proteins that are 
larger than 12 kDa, such as horseradish peroxidase (MW 45 kDa), have been 
found to be trapped in the vasculature.  At the CMJ, horseradish peroxidase 
was also detected between endothelial cells.  As this region is also the “hot 
spot” where trafficking of cells to and from the thymus takes place, the 
extravascular appearance of horseradish peroxidase could be a bystander 
effect, rather than the result of active shuttling.  This hypothesis was 
supported by the fact that the protein remained extracellular.  Only in the 
cortex, a minute amount of cells showed peroxidase activity in vacuoles, 
however, given the natural presence of lipid peroxidases in vacuoles, it 
remains open whether the detected signal comes from the injected protein or 
the expression of endogenous peroxidases86.  More recently, the potential 
uptake of antigenic material from the blood has been revisited.  Intravenous 
injection of cognate protein Ag into TCR tg animals and the consequent 
deletion of thymocytes pointed towards “leakiness” of the blood-thymus 
barrier.  However, given the time scale between i.v. injection and assessment 
of cell death as a read-out for negative selection, alternative explanations 
appear more likely.  For instance, i.v. injection of cognate protein into animals 
with a peripheral protein specific TCR repertoire leads to peripheral T cell 
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activation and causes a cytokine storm that induces massive apoptosis of 
thymocytes87.  Furthermore, it has been shown that DCs deliver peripheral Ag 
as their cargo to the thymus.  Therefore blocking of DCs migration into the 
thymus is an indispensable pre-requisite for these experiments88,89.   
 
 
Introduction 
22 
 
Dendritic cells 
 
This following section is based on the review “Mechanisms and 
consequences of dendritic cell migration” by Alvarez et. al90. 
DCs are specialized antigen presenting cells that play a dual role in inducing 
adaptive immune responses to foreign Ags and in maintaining T cell tolerance 
to self90,91.  DCs consist of several distinct subsets distinguishable by surface 
and intracellular phenotypic markers, immunological function and anatomic 
distribution (Table 2).  In mice, all DCs express (to varying amounts) the 
CD11c integrin and MHC-II molecules, and are further phenotypically 
distinguished by their differential expression of CD8α, CD4, CD11b, Langerin, 
PDCA-1 as well as a growing list of other markers92.  These markers have 
been used in various combinations to define several subpopulations, some of 
which are highly restricted to specific organs whereas others occur at 
characteristic frequencies among a mixture of DC subsets, especially in 
secondary lymphoid organs (SLOs).  Arguably the clearest phenotypic and 
functional distinction can be made between the bulk of CD11chigh MHC-II+ 
cDCs and the type I interferon producing pDCs, which are CD11clow MHC-
II+/low and express unique differentiation markers in both mice and humans.  
Irrespective of their phenotypic idiosyncracies or immunological role, DCs 
exert their activity in discrete locations often remote from their place of origin, 
which implies that DCs possess advanced migratory skills to navigate through 
the body. 
All DCs ultimately derive from hematopoietic stem and progenitor cells 
(HSPCs) in the bone marrow (BM), which give rise to several distinct 
progenitors that can differentiate into one or more DC subsets93-95.  
Facultative DC progenitors are not restricted to the BM (although some fully 
differentiated DCs are generated there) but can be found in multiple locations, 
including blood, lymph, spleen and most visceral organs85,95,96.  These 
progenitors can differentiate into DCs upon challenge in peripheral tissues96. 
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Substantial numbers of DCs are also physiologically generated in the 
thymus90,97. 
 
Table 2.  Traffic molecule profiles of mouse dendritic cells90 
DC subset and phenotype Migratory route Chemokine receptor expression (ligand) Other traffic molecules References 
Precursor DCs 
• Hematopoietic stem and progenitor 
Cell (HSPC) 
CD45+     Lin–    c-Kit+      Sca-1+ 
 
BM 
 
                  Blood (via TD) 
Tissue             SLO 
  Afferent lymphatics  
 
CXCR4 (CXCL12) 
 
VLA-4, LFA-1, CD44, 
PSGL-1, S1P1-4, α4-
integrin, α5-integrin 
 
98 
96 
• Macrophage DC precursor (MDP) 
CD34+      Lin–   c-Kitint     CD11b- 
BM 
 
Blood 
Tissue          Spleen 
CX3CR1 (fractalkine) n.d. 93 
• Common dendritic progenitor (CDP) 
or clonal DC precursor (pro-DC) 
CD34+     Lin–    c-Kitint    Flt-3+ 
BM 
 
Blood 
Tissue           SLO 
n.d. CD44 
L-selectin 
95 
94 
• Monocyte subsets 
CD115+      CD11b+   Ly6Clow/int/high 
F4/80lo        CD62L+/– 
BM 
 
Blood 
Tissue           SLO 
CX3CR1 (fractalkine),  
CXCR4 (CXCL12),  
CCR2 (MCPs),  CCR8(CCL1), 
CCR5 (MIP/RANTES) 
CD99, VLA-4, PSGL-1 99 
100 
Differentiated DCs 
• Langerhans cell 
Langerin+      MHC II+     Dectin-1+ 
CD11b++     CD11c+         CD24a+ 
CD205+      CD45lo           CD8α+/– 
CD103- 
 
Epidermis 
 
Dermis 
 
Afferent lymphatics 
 
LN 
 
Immature 
CCR2 (MCPs), CCR6 (CCL20), 
CX3CR1(fractalkine) 
 
Mature 
CCR7 (CCL19/21), 
CXCR4 (CXCL12) 
 
S1P/S1PR, LFA-1, VLA-4, 
 
101 
102 
103 
• Dermal DC: langerin+ subset 
Langerin+    MHCII+       CD103+ 
CD11blo      CD11cint      CD45hi 
CD8α– 
 
Dermis 
 
Afferent lymphatics 
 
LN 
Immature 
CCR2 (MCPs), 
CX3CR1(fractalkine) 
 
Mature 
CCR7 (CCL19/21) 
P/E selectin ligands 101 
104 
103 
• Dermal DC: langerin- subset 
Langerin–      MHCII+     CD11c+ 
DEC205+      CD24a– 
Dermis 
 
Afferent lymphatics 
 
LN 
Immature 
CCR2(MCPs), 
 
Mature 
CCR7 (CCL19/21),  
CXCR4 (CXCL12) 
S1P/S1PR, LFA-1, VLA-4 102 
• CD8α+ DC 
CD8α+          MHCII+        CD11c+ 
CD4-             CD205+             SIRP-α– 
Blood 
SLO            BM 
Thymus 
Immature 
CX3CR1 (fractalkine) 
Mature 
CCR7 (CCL19/21) 
LFA-1, VLA-4 83 
105,106 
• CD8α– DC 
CD8α–         MHCII+     CD11c+ 
CD11b+       CD4–          SIRP-α+ 
DCIR2+ 
Blood 
SLO            BM 
Thymus 
Immature 
CX3CR1 (fractalkine) 
Mature 
CCR7(CCL19/21) 
LFA-1, VLA-4 106 
83 
105 
• CD8α– CD4+ DC 
CD8α–         CD4+       CD11b+ 
MHCII+      DCIR2+ 
 
 
Blood 
 
Spleen 
Immature 
CX3CR1 (fractalkine) 
Mature 
CCR7 (CCL19/21),  
CCR5 (CXCL13) 
LFA-1, VLA-4 107 
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Table 2 continued.  Traffic molecule profiles of mouse dendritic cells90 
DC subset and phenotype Migratory route Chemokine receptor expression (ligand) Other traffic molecules References 
Differentiated DCs continued 
• pDCs 
B220+         CD11clo     Ly6C+ 
MHCIIlo     CD4–/+       CD8α–/+ 
PDCA-1+ 
(human: CD123+   BCDA-2+, -4+) 
 
Blood 
            
Tissue Thymus SLO BM 
 
Immature 
CCR2 (MCPs),  
CXCR3 (CCL9/10/11),  
CXCR4 (SDF-1), 
CCR5 (MIP/RANTES), 
CCR9 (CCL25)  
Mature 
CCR7(CCL19/21) 
 
L-selectin, ChemR23  
 
108 
109 
110 
111 
112 
• Lung DCs (2 subsets) 
(conducting airways) 
1. CD11bhi        CD11c+      CD103- 
 
(lung interstitium) 
2. CD11blow         CD11c+     CD103+ 
Lung 
 
Afferent Lymphatics 
 
LN 
Immature 
CCR7lo (CCL19/21) 
 
Mature 
CCR7hi (CCL19/21), CCR8 
(CCL1) 
S1P/S1PR, CD38 113 
• Lamina propria DCs (4 subsets) 
1. CD11chigh   CD11b–   CD205+  CD103+ 
2. CD11chigh  CD11b+    CD205+  CD103+ 
3.  CD11cint   CD11bint   CD205–  CD103– 
4. CD11cint   CD11b+     CD205–  CD103– 
Lamina Propria 
 
Afferent Lymphatics 
 
LN 
Immature 
CCR6 (CCL20), CX3CR1 
(fractalkine) 
Mature 
CCR7(CCL19/21), 
CCR8(CCL1) 
n.d. 114 
• Peyer’s Patch DCs (3 subsets) 
1. CD11c+        CD8α+       CD11b– 
2. CD11c+        CD8α–       CD11b+ 
3. CD11c+        CD8α–       CD11b– 
Peyer’s Patches Immature 
CCR6(CCL20), CCR1(CCL9), 
CX3CR1 (fractalkine) 
Mature 
CCR7 (CCL19/21) 
n.d. 114 
 
Fully differentiated DCs are found in healthy tissues as immunologically 
immature cells, i.e. they are equipped with highly active endocytic machinery 
for the sampling of Ags but have not acquired the capacity for full-fledged 
priming of naive T cells115.  Some tissues are notably enriched for DCs, such 
as the skin and mucosal surfaces, the most common sites of entry for 
microbial pathogens, and the SLOs where adaptive immune responses to 
such pathogens are initiated.  Indeed, a central function of DCs in non-
lymphoid tissues is the transport and presentation of antigenic cargo into and 
within SLOs.  This is owed to the DCs’ ability to enter small lymph vessels in 
peripheral tissues and migrate to local draining lymph nodes (LNs). 
Somewhere en route to the LN these Ag-bearing DCs mature, i.e. they 
assume an immunostimulatory phenotype concurrent with increased 
expression of MHC complexes and upregulation of the co-stimulatory 
molecules and cytokines needed for efficient T cell priming.  A small fraction 
of DCs that enter lymphatics are not retained in LNs, but travel along the 
lymphatic tree to the venous circulation.  These blood-borne DCs can deliver 
their antigenic cargo to the spleen85,116 and to primary lymphoid tissues, i.e. 
the BM84,105 and thymus80,83,117-119.   
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Given this complex life cycle, the ability of DCs and their progenitors to 
migrate throughout the body is a critical aspect of their immunological 
function.  The term “migration”, as discussed here, encompasses several 
discrete events that occur in different environments under different biophysical 
conditions, and invoke numerous context-specific cellular and molecular 
mechanisms (Fig. 5).  Specifically, DC migration entails: (1) the ability of 
newly formed DCs or their progenitors to exit their place of origin (i.e. the BM, 
spleen and thymus) and enter the blood; (2) the recruitment of the circulating 
cells into target tissues; (3) the extravascular lodging and interstitial motility 
needed to sample Ags; (4) the capacity to access lymph vessels to travel 
either to LNs or back to the blood; and (5) the ability to interact with migrating 
lymphocytes and other immune cells in a manner that allows the exchange of 
critical information regarding the nature and context of presented Ags.  For 
the purpose of this thesis we will specifically discuss DC migration from the 
blood to primary lymphoid tissues.   
 
Fig. 5.  Programmatic outline of DC and DC 
precursor trafficking routes.  DCs develop from 
precursors that originate from primary lymphoid 
tissues (PLT) such as the BM and the thymus. 
Precursors and committed DCs enter the 
circulation and seed peripheral tissues and 
SLOs. From peripheral tissues, they can access 
afferent lymph upon receiving a mobilization 
signal and travel to the draining LN. Leukocytes 
leave LNs via the efferent lymph and are 
collected in the TD, which eventually guides DCs 
and their precursors back into the circulation90.  
 
Methods to study DC migration 
Many DCs begin their journey with their release from the BM into the blood 
and subsequent traffic into peripheral lymphoid and non-lymphoid tissues. In 
non-lymphoid tissues, DCs eventually proceed into LNs through afferent 
lymphatics and, in some instances, return back to the blood via the thoracic 
duct (TD).  Throughout this journey migrating DCs must apply specialized 
skills to reach their target destination, including the capacity to: traverse 
vessel walls and other anatomic barriers; recognize and adhere to specific 
Introduction 
26 
microvascular endothelial cells in the presence of shear stress in the blood-
stream; sense and follow soluble and surface-bound chemoattractant cues 
through the interstitium; and scan and interact productively with a vast number 
of lymphocytes in primary and secondary lymphoid organs.  Although no 
single method in the immunologist’s toolbox sufficiently covers all the diverse 
steps that constitute a DC’s longwinded journey, the combined application of 
the techniques discussed below has been instrumental to carve out an ever 
more detailed picture of how DC migration impacts physiological and 
pathological immune responses.   
A number of techniques has been particularly useful in studying DC trafficking 
from blood into peripheral tissues or SLOs, such as intravital videomicroscopy 
(IVM)105,120 and flow cytometric or histology-based DC homing assays121, 
which provide useful information at the single-cell and population level, 
respectively.  A detailed analysis of DC interactions with endothelial ligands 
under precisely controlled biophysical conditions is also afforded by the use of 
flow chamber devices122.  Profound insights into DC traffic signals involved in 
transvascular diapedesis and interstitial navigation have been achieved using 
in vitro chemotaxis assays123.   
Trafficking of DCs from tissues to SLOs via the lymph has been exhaustively 
studied, in particular, by classic assays that mobilize DCs from peripheral 
tissues with fluorescent tracers, followed by enumerating the emigration and 
immigration of fluorescent DCs from the periphery and into the draining LN, 
respectively124.  This approach relies on the assumption that the number and 
phenotype of fluorescent DCs recovered from a LN are indicative of their 
migration and not due to acquisition of fluorescent tracer by LN-resident cells.  
A more recent approach involves genetic manipulations that permanently or 
conditionally label DCs through fluorescent proteins driven, for example, by 
promoters for langerin125, CD11c126 and CX3CR1106.  This offers the 
advantage that unperturbed endogenous DCs can be studied in situ, but has 
the potential drawback that reporter expression levels may change during 
maturation or differentiation.  The development of a photoconvertible 
fluorescent protein, Kaede, which upon exposure to UV light shifts its 
excitation and emission spectrum, has emerged as another useful system to 
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monitor the cellular trafficking patterns, including those of DCs, in transgenic 
mice127.  Similarly, the emergence of a photoactivatable GFP (PA-GFP) has 
offered new possibilities to tag cells and has proven useful to gain a better 
understanding of the migratory properties of leukocytes, especially during 
germinal center formation128,129.  Purified or in vitro differentiated DCs have 
also been genetically or chemically labeled and injected into tissues to study 
their trafficking to and function within draining LNs121,130.  This allows for more 
quantitative and time-resolved analyses of the molecular mechanisms, 
kinetics, and immunological sequelae of DC migration.  However, several 
caveats of these approaches must be kept in mind, including the large, non-
physiological numbers of DCs that must be transferred, the need for ex vivo 
manipulation, and that transferred DCs are often not native to the tissue being 
studied.  In this regard, parabiotic or competitive BM chimeric mouse models 
offer advantages for studying physiological recruitment and turnover of DCs 
and, in conjunction with adoptive transfer strategies, have been useful in 
addressing the migration and differentiation of rare DC precursors80,83,85,94-96.   
Technological advances in IVM and multi-photon (MP) imaging have recently 
enabled researchers to directly visualize DC migration and DC interactions in 
their native environment131-133.  Conventional IVM uses brightfield 
transillumination or epifluorescence microscopy that permits two-dimensional 
imaging of intravascular adhesion events in surgically exposed tissues in real 
time134.  This approach has helped to pinpoint the precise role of trafficking 
molecules during DC-endothelium interactions as part of the intravascular 
multistep adhesion cascade.  MP IVM uses infrared-pulsed laser excitation to 
generate high-resolution optical sections of living tissue containing 
fluorescently-labeled cells, such as DCs, migrating and engaging in various 
cell-cell interactions135 (see also section “Multi-photon microscopy”).  
Additional novel imaging modalities have recently been introduced such as 
bioluminescence imaging, magnetic resonance imaging, and positron 
emission tomography which provide non-invasive tracking of leukocyte 
populations, including DCs, throughout the entire body, although with 
considerable less spatial and/or temporal resolution to visualize single-cell 
dynamics136.   
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Traffic molecules in DC migration 
Circulating DCs and their precursors exit the blood in response to tissue-
specific recruitment signals that are displayed on the vascular wall.  These 
include signals that emanate from sites of inflammation (like the pro-
inflammatory chemokines (chemotactic cytokines)) or from normal tissues that 
recruit DC precursors during the initial seeding and subsequent physiological 
turnover of tissue-resident DCs137.  Circulating leukocytes can only follow 
these recruitment signals by engaging adhesion molecules, which allow them 
to withstand the shear stress exerted by microvascular blood flow and to 
commence transvascular movement into the target tissue.  DCs express 
specific adhesion molecules and maturation-dependent chemoattractant 
receptors that allow them to respond to a variety of ligands138,139, which 
control their trafficking.  For example, to access non-lymphoid peripheral 
tissues and navigate within them, immature DCs (and some of their 
precursors, particularly monocytes) utilize specific chemokine receptor-ligand 
pathways, such as CCR2 – CCL2 (MCP-1)99,140, CCR5 – CCL5141,142, and 
CCR6 – CCL20143.  When DCs become mature they downregulate their 
responsiveness to these inflammatory chemokine pathways and traffic to the 
draining LNs by upregulating CCR7, which responds to two ligands, CCL19 
and CCL21144-146.  These chemokines are expressed by peripheral lymphatic 
endothelial cells as well as LN stroma cells and guide DCs to downstream 
LNs147-149. 
DCs and their precursors are recruited from blood into tissues (except the 
spleen) following a cascade of sequential molecular and cellular interactions, 
analogous to what has been shown for the extravasation of other circulating 
leukocytes.  According to this paradigm, leukocyte extravasation occurs in a 
series of distinct steps including tethering, rolling, activation by a 
chemoattractant, firm adhesion, and diapedesis150.   
On most leukocytes, including circulating DCs, tethering and rolling are 
primarily mediated by one or more of the three members of the selectin family 
and occasionally by α 4 integrins.  Two selectins, P- and E-selectin, are 
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expressed on activated endothelium, whereas L-selectin is found on 
leukocytes.  Selectins bind sialyl-Lewis X-like carbohydrates presented by 
sialomucins, such as P-selectin glycoprotein ligand 1 (PSGL-1)151.   
Rolling cells must next encounter a chemoattractant stimulus, often (but not 
always) in the form of a chemokine presented on venular endothelial cells152.  
Most chemoattractants signal through pertussis toxin (PTX)-sensitive G 
protein-coupled receptors (GPCRs), causing clustering and conformational 
activation of integrins.  Activated integrins, in particular LFA-1 (αLβ2), VLA-4 
(α4β1), Mac-1 (αMβ2) and α4β7 mediate firm arrest of the rolling cells by binding 
to members of the immunoglobulin superfamily (IgSF), including ICAM-1 
(ligand for LFA-1 and Mac-1), ICAM-2 (ligand for LFA-1), VCAM-1 (ligand for 
VLA-4 and weakly for α4β7) and MAdCAM-1 (ligand for α4β7)153.   
Upon firm arrest, leukocytes respond to localized chemoattractant and/or 
adhesion molecule gradients, which provide guidance cues for diapedesis and 
directed leukocyte migration.  The essential molecular determinants involved 
in tethering, rolling, firm adhesion and diapedesis are expressed by both 
circulating DCs and precursors that can give rise to DCs, such as 
monocytes154 and HSPCs155.  Indeed, IVM experiments have determined that 
both cDCs and pDCs tether and roll efficiently along venular endothelium in 
an E- and P-selectin dependent fashion and, like other inflammatory cells, can 
be recruited from the blood to sites of inflammation109,120.   
The combinatorial use of selectins, chemoattractant receptors, integrins and 
their respective ligands provides for a great deal of diversity and selectivity in 
regulating leukocyte migration to distinct tissues156. Individual leukocyte 
subsets, including DCs, express only a small selection of the broad palette of 
traffic molecules and, therefore, can only successfully participate in one or a 
few specific multi-step cascades. Conversely, many specialized microvascular 
endothelial cells present a highly tissue-specific assortment of adhesion 
molecules and chemoattractants, thus providing a unique tissue- and 
situation-specific molecular “area code”. In the subsequent section, we 
highlight specific examples of how multi-step adhesion cascades control the 
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movement of intravascular DCs and their precursors into different target 
organs.   
 
DC migration from blood to tissues 
Blood contains both DC precursors and differentiated DC subsets, including 
pDCs and cDCs, which are a mixture of newly generated cells from the BM 
and of experienced DCs that have re-entered the circulation from peripheral 
tissues124.  There are also pluripotent HSPCs, which recirculate continuously 
between the blood, peripheral organs and draining lymphatics and can give 
rise to DCs upon TLR ligation96.  Blood contains also lineage-committed BM-
derived DC precursors that can differentiate into any DC subset found in 
SLOs93-95.  An additional source of DCs are circulating monocytes157.  Two 
monocyte subsets have been identified in mice and humans that are 
distinguished by the differential expression of Ly-6C (in mice) and three traffic 
molecules, CX3CR1, CCR2 and L-selectin99,158. Ly-6ChighCX3CR1lowCCR2high 
(“inflammatory”) monocytes are preferentially recruited to distressed tissues in 
a CCR2 – CCL2 dependent manner. They can give rise to a variety of 
conventional DCs under both inflammatory and steady-state conditions. The 
second subset, Ly-6C–CX3CR1highCCR2–/low (“resident”) monocytes, interacts 
with fractalkine (CX3CL1), a transmembrane chemokine on resting 
endothelium. These cells patrol along the luminal surface of microvessels, 
enter tissues upon inflammation and differentiate into macrophages99,159.   
An abrupt increase in circulating DC numbers occurs when DCs are injected 
intravenously (i.v.).  Although non-physiological, such events are clinically 
relevant because antigen-pulsed autologous DCs have been given to patients 
by various routes as anti-cancer vaccines91,160.  This clinical context highlights 
the importance of understanding the target organs of circulating DCs and the 
molecular mechanisms that govern their migration to those sites.  Irrespective 
of their origin and differentiation state, circulating DCs and their precursors 
gain access to lymphoid and non-lymphoid tissues through multi-step 
adhesion cascades.  The molecules involved in discrete adhesion steps vary 
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depending on the DC subset and the target tissue, thus providing specificity 
and selectivity in recruitment (Fig. 6).   
 
Fig. 6.  Hematogenous DC routes90. This schematic outline illustrates various routes 
that DCs can take to and from the blood into various lymphoid and non-lymphoid 
tissues. DC precursors are released from the BM and enter the blood pool, which 
consists of: conventional DCs (or cDC), pDCs, and DC precursors (encompassing 
monocytes, HSPCs, and other committed DC precursors). Potential destinations of 
blood-borne DCs as well as the major trafficking molecules implicated in their 
migration are highlighted, including (from left to right) the skin, LN, thymus, and 
spleen, as well as their re-entry into the BM. 
 
DC traffic to non-lymphoid tissues 
The recruitment mechanisms that guide fully-committed immature or mature 
DCs from blood into non-lymphoid tissues are only partly characterized.  Our 
current knowledge is mainly based on adoptive transfers of labeled DCs by 
i.v. injection.  A major fraction of injected mature and immature DCs 
accumulate in the liver and lungs in mice and humans105,161,162.  Though the 
underlying mechanisms governing this distribution are poorly understood, the 
retention of DCs in the lungs is probably due, at least in part, to mechanical 
trapping in pulmonary capillaries, rather than active adhesion105.   
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IVM experiments have shown that cDCs can efficiently tether and roll in 
normal murine skin venules, which constitutively express E- and P-selectin120.  
Because sLeX-decorated PSGL-1, the principal ligand for the vascular 
selectins, is not only highly expressed on DCs120, but also on monocytes and 
HSCs155,163, it is likely that all DCs and DC precursors can engage in rolling 
interactions in microvascular beds that express P- and/or E-selectin either 
constitutively (e.g. in skin, BM and thymus) or in response to inflammation.  
Interestingly, DC extravasation into inflamed skin depends on selectins but 
not on PSGL-1, suggesting a contribution by other selectin ligands on DCs164.   
Although selectins are clearly important, they mediate only the first step in the 
multistep adhesion cascade and do not by themselves support DC arrest or 
accumulation in normal skin.  Additional signals are required to trigger integrin 
activation, arrest and subsequent diapedesis120,164.  However, little is known 
about the inflammation-induced or constitutive chemoattractants that trigger 
these steps.  Direct experimental observations of steady-state DC recruitment 
to normal tissues are particularly challenging, because these are very rare 
events that may only become prominent after long-term adoptive transfers or 
in parabiosis settings.  Some information may be gleaned from in vitro 
experiments.  For example, a recent study found a role for the IgSF molecule 
ICAM-2 in the transmigration of immature DCs across endothelial 
monolayers165.   
Lineage-committed DC precursors (other than monocytes) have not been 
examined so far for their capacity to home to normal tissues other than SLOs.  
Reconstitution experiments in irradiated mice with wildtype (wt) and mutant 
BM have shown that circulating langerhans cells (LC) precursors repopulate 
severely inflamed skin in a CCR2- and CCR6-dependent manner, but these 
pathways are apparently not operational in normal skin140,143.  Accordingly, 
the CCR2 ligands, CCL2 and CCL7, and the CCR6 ligand, CCL20, are poorly 
expressed in resting tissues, but markedly increased in inflamed skin140,143,166.   
The so-called inflammatory CX3CR1lowCCR2+Ly6Chigh monocytes can enter 
diverse inflamed tissues, including the skin, lung, and intestinal lamina 
propria, where they give rise to various DC subsets167-169.  The CX3CR1high 
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CCR2– Ly6Clow monocytes can also give rise to DCs (or at least CD11c+ cells) 
in the lung169 and atherosclerotic plaques170.  However, the role of specific 
traffic molecules in each case is largely unclear.  Arguably the best evidence 
exists for CCR2, since Ly6Chigh monocytes fail to accumulate at sites of 
inflammation in Ccr2–/– mice140.  However, it must be noted that CCR2 
controls the inflammation-induced release of monocytes from the BM171.  
Thus, the observed migration defect could either reflect poor monocyte 
mobilization or defective peripheral recruitment, or both.   
Circulating pDCs can also access inflamed tissues, but their homing 
properties are thought to differ substantially from those of conventional DCs.  
Compared to the latter, human pDCs exhibit only a weak capacity in vitro to 
migrate towards pro-inflammatory chemokines (e.g. CCL2, CCL5, and 
CCL20) despite expressing a similar chemokine receptor profile (e.g. CCR2, 
CCR5, CXCR3, CXCR4, and CCR7)110.  On the other hand, pDCs migrate 
effectively towards CCL19 and CCL21, two homeostatic chemokines that act 
on CCR7 and are constitutively expressed in SLOs110.  Indeed, substantial 
numbers of pDCs are found in SLOs but they are relatively infrequent in most 
non-lymphoid tissues.  In humans, pDCs are enriched in certain inflamed non-
lymphoid tissues, such as lupus erythematosus lesions172, psoriatic skin173 
and the nasal mucosa of allergic rhinitis patients174, but it has not been 
determined if their presence at those sites reflects recruitment of differentiated 
circulating pDCs or local differentiation from progenitors.  Direct recruitment of 
blood-borne pDCs have been documented in normal and inflamed small 
intestine in mice; pDCs require CCR9 to access the intestinal wall, which 
physiologically generates CCL25, the ligand for CCR9175.  Another 
chemoattractant for circulating pDCs is chemerin111,112.  This non-chemokine 
molecule is generated by serine proteases that are activated during 
coagulation, fibrinolysis, and inflammation.  Chemerin is absent from normal 
skin but is markedly upregulated during cutaneous inflammation and recruits 
pDCs via the serpentine chemokine-like receptor 1 (CMKLR1 or ChemR23). 
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Dendritic cell traffic to BM 
Some fully committed DCs recirculate from peripheral tissues via the draining 
lymphatics and blood into primary lymphoid tissues.  Through this tortuous 
route, DCs can deliver Ag from all over the body to both the BM and the 
thymus.  However, immunological consequences in each tissue are markedly 
different.  The BM shares a number of features with bona fide SLOs and 
serves as a major reservoir for memory T cells176. Ag-laden circulating DCs 
that home to the BM evoke a vigorous memory response that leads to rapid 
proliferation and peripheralization of responsive T cells105.  Immature and 
mature DCs enter the BM equally well by employing a multi-step adhesion 
cascade.  IVM in mouse skull BM has shown that rolling is mediated by 
interactions of PSGL-1 with P- and E-selectin in BM venules and sinusoids, 
whereas VLA-4–VCAM-1 is required for sticking.  Although DCs express β 2 
integrins, homing to the BM is independent of these molecules.  DC homing to 
BM is also not affected by PTX treatment, suggesting that DCs may use an as 
yet unidentified chemoattractant receptor(s) that does not signal through the 
conventional Gαi pathway to activate VLA-4105.   
 
Dendritic cell trafficking to the thymus 
Thymic DCs play a key role in generating a self-tolerant T cell repertoire by 
presenting harmless sAgs to developing T cells during negative selection79.  
According to the expression of their surface markers, thymic CD11c+ MHC-II+ 
DCs can be further subdivided into CD8α+CD11b– and CD8α–11b+ cDC and 
pDCs.  Up to 30% of pDCs and CD8α+ DCs carry IgH rearrangements of the 
TCRα chain, indicating that the have developed from DN2/DN3 cells81.  In line 
with this, CLP as well DN1-3 cells can give rise to thymic DCs, though with 
decreasing efficiency43.  T lineage commitment of T cell progenitors is 
achieved by expression of Notch and likewise deletion of Notch1 drives DCs 
rather than T cell development of precursor cells in the thymus43.  The 
accumulation of thymic DCs in the medulla, especially of CD11c+11b– DCs is 
at least in part regulated by the expression of XCL1 by mature MHC-IIhigh 
mTECs and XCR1 by the DCs82.   
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It has also been shown that fully differentiated, yet immature DCs have the 
capacity to home to the thymus.  Thus, the thymus harbors two distinct 
populations of DCs; one is derived from intrathymic lymphoid progenitors, 
whereas the second population originates from the periphery68,119,177. 
Monocytes or DC precursors have not been observed to home to the 
thymus94,99.  By contrast, parabiosis and adoptive transfer experiments have 
established that small numbers of fully differentiated DCs constantly enter the 
thymus from the blood80,83,117,119.  It is not clear whether or not all immature 
DC subsets share the same ability to home to the thymus.  Adoptive transfer 
experiments of splenic Flt3L-expanded DCs led to the conclusion that all DCs 
subsets home to the thymus equally well83, however, this finding has been 
challenged recently.  It was shown in parabiotic mice that CD8α+11b– cDCs 
arise locally in the thymus while pDCs and CD8α–11b+ cDCs can enter the 
organ from the periphery80,119.  Inflammation-induced maturation selectively 
blocks the capacity of DCs to home to the thymus, but does not compromise 
DC trafficking to other organs83.   This suggests a mechanism to safeguard 
against inadvertent deletion of T cells that recognize pathogen-associated 
Ags, which are much more likely to be presented by mature than immature 
DCs.  The differential capacity of immature DCs to access the thymus is 
probably regulated by an organ-specific multistep adhesion cascade, whereby 
rolling and sticking are mediated by PSGL-1–P-selectin and VLA-4–VCAM-1, 
respectively. Unlike in the BM, DC entry into the thymus is PTX sensitive, but 
the specific Gαi-coupled chemoattractant receptor(s) remain(s) to be 
identified83 (Fig. 7).   
Upon entering the thymus, homed DCs upregulate maturation associated 
markers such as MHC-II and CD8080.  They localize almost exclusively in the 
medulla with a slight enrichment at the CMJ.  Homing of DCs to the thymus 
has been shown to be an important tool to deliver peripheral Ag to the thymus 
and to make it available for negative selection83,84.  Thymic DCs still maintain 
the capacity do proliferate and may undergo one or two cell divisions upon 
entering the organ80.  It is possible that this is a mechanism to prolong the 
persistence of Ag similarly to cycling splenic DCs whose daughter cells 
continue to present captured Ag85.  
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Fig. 7.  DCs home to the thymus by employing a multi-step adhesion cascade.  
Rolling is mediated by PSGL-1 – P-selectin and VLA4 – VCAM-1 interactions.  
Integrin activation relies on at least one, yet unidentified GPCR and firm arrest is 
promoted by VLA-4 – VCAM-1.   
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Multi-photon microscopy 
 
Multi-photon microscopy (MPM) has itself proven to be a particularly useful 
tool to visualize fluorescently tagged structures deep within tissues.  Unlike 
conventional fluorescent microscopy, which utilizes one-photon excitation, 
MPM operates at lower laser powers and longer wavelengths.  With a 
penetration depth of up to 500 µm as compared to ~100 µm for conventional 
confocal microscopy, MPM appears to be far superior.  The enhanced 
penetration depth is mainly owed to the infrared excitation.  MPM relies on the 
principle that the energy of two photons has to add up in order to excite 
fluorescent molecules.  For instance, GFP has an excitation maximum of 
about 488 nm for one-photon excitation.  As MPM relies on the additive effect 
of two photons, the excitation optimum of GFP for MPM is ~970 nm (Fig. 8a).  
Enough energy is only provided at the focal point where two photons meet to 
excited fluorescent molecules.  As the focal point is very small and confined, 
excitation of surrounding tissue is efficiently prevented which results in 
dramatically reduced photo-bleaching and photo-toxicity (Fig. 8b).  However, 
one has to keep in mind that infrared excitation produces heat, and thus 
actual overheating of the tissue sample is a bigger hazard for MPM as 
compared to conventional fluorescent microscopy134,135,178,179.   
The combination of MPM with time-lapse IVM has greatly advanced our 
current understanding of leukocyte motility and the interplay of different 
immune cells, especially in LN.  We will here discuss considerations for 
performing time-lapse MP IVM and parameters that can be extracted from MP 
IVM to describe fluorescently tagged immune cell “behavior”90,134,180.   
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Fig. 8.  Comparison of one-photon and multi-photon excitation.  (a) For one-photon 
microscopy, one photon provides enough energy to elevate the energy status of a 
fluorescent molecule from the ground state to the excited state, while in multi-photon 
activation the additive energy of at least two photons is required.  After non-radiative 
relaxation, the fluorescent molecule returns to the ground state by emitting light.  (b) 
One-photon excitation occurs along the laser beam, while multi-photon excitation can 
only occur at the focal point where two or more photons meet.   
 
MP IVM relies on the acquisition of an imaging volume at given time points 
over a predetermined time period.  In order to gain information about three 
dimensional (3D) cell behavior, optical section along the z-axis are being 
acquired.  Without a doubt, operating at minimal gap sizes between the 
optical sections and covering large, high resolution imaging volumes provides 
the highest possible optical and spatial resolution.  High-resolution images 
tend to facilitate post acquisition image processing.  Despite this, the large 
amount of data may make computation analysis time consuming as it causes 
imaging programs to run less stably.  One also has to keep in mind that 
acquiring large amounts of data will prolong the minimal cycle time between 
the acquisitions of the imaging volumes.  Consequently, the temporal 
resolution of cellular processes will be compromised.  High-resolution z-stacks 
also require a relatively long exposure time as compared to lower resolution z-
stacks, which greatly increases the probability to cause tissue damage and 
photo-bleaching.  To avoid this, one can work with minimal resolution z-stacks 
that cover smaller volumes, the gap size between optical sections is bigger 
and the optical sections per se are of lower resolution.  The advantage of this 
clearly lies in the opportunity to acquire z-stacks at shorter time intervals and 
thus, gaining better temporal resolution.  Also photo-toxicity is markedly 
reduced when using minimal resolution z-stacks.  However, the spatial and 
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optical resolution is compromised, meaning post-acquisition image processing 
may prove challenging due to the lower optical resolution.  Taken together, 
clearly the question one seeks to answer with a given experiment dictates the 
priorities and the compromises that have to be made between spatial and 
temporal resolution134,181.   
After acquisition, the individual optical sections of each recorded fluorescent 
channel of the time-lapse recording are compiled into a four dimensional (4D) 
movie (consisting of x, y, z and time parameters) using image processing 
software.  The movie is further analyzed by identifying and tracking of single 
cells.  Basically, a cell’s track consists of a sequence of x, y and z positions 
that are linked to their corresponding time points within the movie.  Using this 
information, one can extract a variety of parameters to describe the cells 
motile behavior (Table 3).   
Table 3.  Measurement parameters used for MP IVM134,179 
Parameter Description Unit 
3D instantaneous velocity 
(3DIV) 
Velocity measured during a defined time interval (t), 
e.g., v01 = d01/t01 
µm/min 
Mean velocity per track (V) Mean velocity of a cells track, e.g., V0n = (v01 + v12 + 
v23 + …) / n 
µm/min 
Displacement (d) Distance between first and last imaging point, e.g., d0n 
= √(∆x0n
2 + y0n
2 + ∆z0n
2) 
µm 
Mean displacement (MD) Average distance migrated from arbitrary points of 
origin over a selected time (t) representing a multiple of 
the scan interval (si), e.g., MD(t=1si) = (d01 + d12 + d23 
+ d34 + … dn–1n)/n; MD(t=2si) = (d02 + d13 + … dn–2n) 
/ (n-1) 
µm 
Motility coefficient (M) A measure for a cell’s propensity to move away from its 
point of origin, analogous to the diffusion coefficient of 
Brownian motion, e.g., M = d2/6t 
µm2/min 
Meandering index (MI) A measure for the directionality of cell migration.  
Represents the ratio of the displacement (d) over the 
total path length e.g., MI = d0n / (d01 + d12 + d23 + 
… dn–1n) 
N/A 
Turning angle The angles at which a cell deviates from a straight line 
between subsequent measurement intervals.   
degrees 
Shape index Measure for a cells polarization, long axis / short axis N/A 
 
One of the most commonly used motility parameters is velocity.  Velocity is 
the displacement of a cell over time.  Given that most cells do not migrate in a 
strictly straight line, the mean velocity per track is calculated as the velocity 
between frames (instantaneous velocity) of each track and then averaged with 
the track.  As mentioned before, a cell’s migration path rarely follows a 
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straight line and consequently instantaneous velocity is a parameter that is 
influenced by the cycle time at which the time-lapse recording was acquired.  
For instance, shorter time intervals (e.g. 15 sec) will reveal twists and turns in 
the cells’ migratory path that cannot be detected using longer cycle times (e.g. 
60 sec).  Consequently, the path length of a cell may appear shorter and more 
directional meaning that the same cell appears to migrate at lower velocities.  
As to date it is not possible to acquire 4D MPM movies at real-time, one has 
to assume that the calculated instantaneous velocities are biased towards 
underestimating the real migration speed to varying degrees depending on 
the cycle time.   
A potential pitfall that is specific to all parameters that are expressed per 
track, such as mean velocity per track, lies in the accuracy of the cell tracking 
software.  In the simplest setting, automated cell tracking software identifies 
objects in a predetermined size range whose fluorescence intensities 
significantly deviate from the background noise.  These parameters are set by 
the individual operating the software and are customized for each fluorescent 
channel and recording separately.  The tracking software then identifies the 
objects, reduces them to their geometrical center and applies mathematical 
models to identify the same cell in different frames of the movie that ultimately 
make up one track.  The most commonly used models are the Brownian 
motion algorithm and autoregressive motion algorithm.  The Brownian motion 
algorithm identifies the most likely path connection between two geometrical 
centers in any direction with a distance constraint.  In contrast the 
autoregressive algorithm utilizes the displacement (position, speed and 
direction) of a cell’s geometrical center between the previous and the current 
frame to extrapolate a model and predict the location of the geometrical 
center in the next frame and then identify the geometrical center that comes 
closest to this prediction.  This cell is then incorporated into the track and the 
process repeats.  Because it is easier to predict the movement of slow moving 
cells than fast moving cells (with either algorithm), tracks of fast moving cells 
are prone to errors.  Specifically, there is a small tendency towards identifying 
the “wrong” cell as a part of the track, which results in the fusion of two 
separate tracks into one.  At times, these tracks can be relatively far apart and 
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consequently, a bias towards higher velocities per track is introduced.  
Another pitfall is that tracks of fast moving cells have a tendency towards 
being split up in several tracks, thus resulting in an over-representation of the 
number of fast moving cell tracks as compared to slow moving cell tracks, and 
further exacerbating the bias toward high velocities.  To summarize, the 
instantaneous velocity tends to be an underestimate owing to the non-real 
time data acquisition.  Conversely, the mean velocity per track can be biased 
towards fast moving tracks and may thus overestimate the actual velocity.  As 
instantaneous velocity is less affected by manually / post acquisition 
introduced errors, it is generally believed that this parameter reflects a cell’s 
real velocity more accurately as compared to mean velocity per track. 
Another commonly used motility parameter is the motility coefficient.  Similarly 
to the Brownian diffusion coefficient, it describes the propensity of a cell 
population to move away from an arbitrary point of origin, or to put in other 
words, it measures how fast cells “diffuse” from their point of origin.  This 
parameter can be derived by graphing the mean displacement of a cell 
population versus the square root of time.  The mean displacement is 
calculated for each cell for all frames of a track.  It is the mean of 
displacement between the location at the origin of the track (at t0) and the 
cells’ location at subsequent time points (at t1n, Fig. 9a).  Plotting the mean 
displacement versus the square root of time results in a graph that provides 
information about the quality of the migration on the population level.  The 
resulting graph typically consists of an initial, non linear segment, followed by 
linear relation of displacement and the square root of time.  A persistent linear 
relation indicates random migration.  A plateau is characteristic for confined 
migration while branching off from the linear regression to the other side is a 
hallmark for directed migration (Fig.9b).  Furthermore, the regression line of 
the graph that fits the linear segment can be used to calculate the motility 
coefficient134,181 (Table 3).   
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Fig. 9.  Scheme of a displacement and mean displacement plot.  (a) Schematic of the 
migration path (dashed line) and displacement (d, red line) of a cell at given time 
points (t).  (b) Random migration is indicated by a linear relation between mean 
displacement and the square root of time (black line), faster displacement indicates a 
directed migration pattern (red line), slower displacement represents confined 
migration (blue line).  Over short periods of time, cells tend to displace faster than 
random (dashed line, persistent motion).   
 
The meandering index is a popular parameter to further describe the 
mirgratory path of the cells.  It is widely used and known under several 
different names, such as chemotactic index, confinement ratio or straightness 
index.  Despite the different names, it is always calculated by dividing the 
tracks displacement by the path length.  If the track is a straight line, the 
meandering index is 1, if the cell’s first and last location is the same, e.g. if it 
didn’t move at all or moved in a perfect circle, the meandering index is 0134,181.   
A less commonly used parameter is the turning angle, which measures the 
deviation of the migration path in subsequent frames.  This measure also 
provides information about the directionality of the migration134. 
Lastly, by measuring the surface of a cell rather than its geometrical center, 
one can gain information about its shape and the change in shape over time.  
A cell’s roundness is usually measured by the shape index, which is 
calculated by dividing the short axis by the long axis.  A perfect sphere has a 
shape index of 1, while a perfect line has a shape index of 0.  Notably, this 
index does not give any information about the volume of the cell179.   
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Aims of the thesis 
 
A functional immune system has to protect the body from pathogens while 
being tolerant to self-antigens. To achieve this goal, developing thymocytes 
are subject to tolerance mechanisms.  Central tolerance takes place within the 
thymus and removes the bulk of auto-reactive thymocytes by either clonal 
deletion (negative selection) or redirection of auto-reactive thymocytes into a 
regulatory T cell lineage.  DCs are key players in this process.  They acquire 
and present self-peptide in the context of MHC molecules to thymocytes and 
can either promote survival or apoptosis of interacting T cells.   
Thymic DCs consist of two major subsets that can be distinguished according 
to their surface markers: cDCs and pDCs.  They can also be differentiated 
according to their place of origin.  Thymus resident DCs differentiate locally 
from a progenitor cell, while homed DCs enter the thymus fully differentiated 
from the blood.   
Until recently, the analysis of the crosstalk of different cell types within the 
thymus has been limited to conventional histological approaches182 and thus 
cannot provide any data about the dynamics of interactions.  Recently, this 
limitation has been overcome by employing MP IVM. 
Bousso et al. used reaggregated thymic organ cultures (RTOCs) in 
combination with MP IVM to visualize encounters between thymocytes and 
stromal cells183.  Though this in vitro system provides all cell types present in 
a native thymus, the thymic architecture is disrupted.  It can be concluded 
from recent studies about thymic organization, that intact cortical and 
medullary regions are indispensable for central tolerance184.  Additionally, this 
system cannot provide important factors such as a constant blood flow or 
innervation that may influence cellular dynamics within the thymus.  
Other studies took advantage of so called acute thymic slice preparation to 
visualize thymocyte – APC interaction during positive selection185,186.  This 
approach enables one to follow developing T cells within the cortex and 
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medulla.  However, the disadvantage of this set up is that the preparation of 
the thymus requires a broad range of different temperatures ranging from 4°-
37°C that may influence cellular behavior.  Also, factors like blood flow or 
innervation cannot be provided in this in vitro system.  On the other hand, the 
thymus’ normal anatomic localization within the thorax makes intravital 
imaging strategies extremely challenging. In particular, to observe individual 
migrating intra-thymic cells and their interactions with other thymic 
constituents, it is necessary to generate 3D recordings of cells of interest over 
time intervals ranging from minutes to hours.  Even subtle tissue movements 
would result in motion artifacts that render imaging data uninterpretable.  
Since the thymus is in direct contact with both the heart and the lungs, it 
would be extremely difficult to obtain useful imaging information from 
orthotopic thymi in living animals.   
We aimed to circumvent these shortcomings by transplanting embryonic 
thymus lobes under the kidney capsule of recipient mice.  Using this system 
we were able to visualize T cell behavior in the thymus under selecting and 
non-selecting conditions.  We also specifically focused on DCs as to date, it is 
poorly understood whether thymus resident versus homed DCs exhibit 
specialized functions in T cell selection.  We employed MP IVM combined 
with a broad range of other experimental strategies to address whether 
resident versus homed DCs differed in the mechanisms they used to acquire 
peripheral Ag for presentation to T cells.   
Specifically, we have addressed the following four specific aims: 
 
Aim 1: To establish MP IVM for transplanted thymi 
This aim focused on the establishment and optimization of the first model of 
MP IVM of intact murine thymus lobes.  The endogenous thymus in mice is 
inaccessible to IVM due to motion artifacts, a result of its anatomical location.  
To circumvent this, we took advantage of a transplantation model.  This aim 
covers the transplantation of embryonic thymi, the analysis of the grafts 
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(subaim 1.1) and development of the imaging strategy for MP IVM (subaim 
1.2).   
 
Aim 2: To analyze the motile behavior of thymic DCs and T 
cells 
We asked whether we could identify cortex and medulla in transplanted 
animals in vivo (subaim 2.1), describe the motile behavior of thymocytes and 
DCs in cortex and medulla (subaim 2.2) and address how thymocyte 
migration is altered when they encounter homed DCs that present cognate Ag 
(subaim 2.3).  These experiments revealed important insights in T cell 
development and the dynamic interaction of thymocytes with DCs and refined 
our understanding of negative selection. 
 
Aim 3: To analyze homed versus thymus resident DCs 
This aim tested the hypothesis that homed and thymus resident DCs display a 
different motility behavior.  We addressed this by visualizing homed and 
thymus resident DCs in the same imaging volume using MP IVM.  This aim 
highlighted differences of thymic DCs according to their origin and provided 
important clues as to whether these subsets exhibit specialized functions.  
 
Aim 4:        To test whether thymus resident DCs acquire 
blood borne Ag 
We aimed to test whether thymic DCs that are closely associated with 
vascular structures could breach the endothelial layer and thus, gain access 
to blood borne components, such as antigenic material.  To test this, we 
investigated whether thymic DCs could be stained in vivo by an intravenously 
administered mAb (subaim 4.1).  We addressed the possibility of a 
specialization of thymus resident versus homed DCs in the formation and 
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extension of transendothelial protrusions into the blood stream by intravenous 
mAb labeling (subaim 4.2).  Furthermore, we administered blocking mAb to a 
variety of candidate molecules to assess the mechanism by which thymic DCs 
gain access to the blood (subaim 4.3).  The proposed experiments in this aim 
helped us gain a better understanding of whether and how circulating proteins 
can be picked up by thymic DCs.   
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Results 
 
Aim 1: To establish MP IVM for transplanted thymi 
Subaim 1.1: To analyze transplanted thymi 
Transplanted thymus – anatomy and cellular composition 
 
The thoracic thymus is inaccessible to perform MP IVM as it is located within 
the rib cage and directly contacts the heart and the lungs.  We attempted 
several transplantation models to circumvent this shortcoming.  Grafting 
embryonic thymi on the skull of recipient mice did not yield good results due to 
the poor engraftment and extensive formation of scar tissue (not shown).  We 
eventually succeeded by transplanting embryonic thymi under the kidney 
capsule of recipient mice.  The best results were achieved when single 
thymus lobes from gestation day E14.5-18.5 embryos were grafted under the 
left kidney capsule of four-week old male recipient mice.  Transplanting into 
female mice led to the formation of extensive connective tissue between the 
graft and the ovaries, thus, rendering consequent exposure of the graft for MP 
IVM difficult and inefficient.  Thymi were grafted under the left kidney capsule 
of recipient mice, which is anatomically more distal to the respiratory tract 
than the right one.  Additionally, the spleen is located between the left kidney 
and the liver, functioning as an important spacer that prevents the formation of 
highly vascularized adhesions between liver and kidney, which were often 
observed when grafts were transplanted under the right kidney capsule (Fig. 
10).  We chose four-week old mice as recipients, an age at which the animals 
were old enough to endure the surgery, yet young enough at the time of 
imaging four weeks after transplantation to observe the thymus at its peak 
cellular output.   
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Fig. 10.  Mouse anatomy – kidneys.  
Unlike in humans, in mice the left 
kidney is anatomically more distal to 
the thorax and the vascular stem that 
is feeding the organ with blood (vena 
and arteria renalis) is longer as 
compared to the right kidney.   
 
In agreement with previous publications, we obtained good thymus 
engraftment, revascularization and T cell development by four weeks post-
transplantation187.  At that time, grafted thymi closely resembled their 
endogenous counterparts.  They had developed cortical and medullary 
regions and the distribution of CD11c+ DCs and PECAM-1+ vessels was also 
normal.  In transplanted and endogenous thymi, CD11c+ DCs were most 
abundantly present in the medulla, followed by CMJ and the cortex.  In 
contrast, PECAM-1+ vessels were evenly distributed throughout the thymus 
(Fig. 11a-d).  Furthermore, the same DC subsets could be identified in 
endogenous and transplanted thymi.  Thymic cDCs and pDCs were present at 
the same ratios.  Thymic DCs are composed of a large fraction of pDCs 
(~50%), followed by CD11c+CD8α+CD11b– and CD11c+CD8α–CD11b+ cDCs 
in twelve-week-old male mice.  In contrast, splenic DCs mainly consist of 
CD11c+CD8α+CD11b– and CD11c+CD8α–CD11b+ cDCs, with only a small 
fraction being pDCs (~10%).  Other DC subsets such as CD11c+CD4+CD8– 
and CD11c+CD4–CD8– DCs can also be found at low frequencies in spleen 
and thymus and have been combined here as “other DCs” (Fig. 11e).  It is 
noteworthy that similar to the cortex-to-medulla ratio, which decreases with 
time as the thymus involutes, the subset contribution of DCs was also 
subjected to change with advancing age of the animals.  With age, the 
percentage of pDCs increased at the expense of CD11c+CD8α–CD11b+ cDCs 
(unpublished observation).  Transplanted thymi supported T cell development 
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(Fig. 11f) and restored the T cell pool of athymic nude mice that are otherwise 
devoid of T cells188.  
 
Fig. 11.  Transplanted thymi closely mirror their endogenous counterparts.  Embryonic 
thymi were transplanted under the kidney capsule of recipient mice and endogenous and 
transplanted thymi were analyzed four weeks later.  (a, b) For immunofluorescence, 
cryosections were stained with mAbs against cytokeratin 8 (red, a, b), CD11c (white, a) or 
PECAM-1 (white, b) and the lectin UEA-1, that specifically binds to mTECs (green, a, b).  
Cortex, medulla and CMJ were identified according to the cytokeratin 8 staining.  Shown 
are representative confocal images of endogenous (upper panel) and transplanted thymi 
cortexCMJmedulla cortexCMJmedulla cortexCMJmedulla
Tr
an
sp
la
nt
ed
Cytokeratin 8 UEA-1 CD11c
a
En
do
ge
no
us
UEA-1 CD11cCytokeratin 8
En
do
ge
no
us
Tr
an
sp
la
nt
ed
b UEA-1 PECAM-1Cytokeratin 8
Cytokeratin 8 UEA-1 PECAM-1
CD8 
CD
4 
0 10 2 10 3 10 4 10 5
0
10 2
10 3
10 4
10 5
0 10 2 10 3 10 4 10 5
0
10 2
10 3
10 4
10 5 4.55 ± 0.1 5.51 ± 0.2 92.1 ± 0.35
0.93 ± 0.04 1.47 ± 0.161.16 ± 0.02
93 ± 0.15
1.36 ± 0.04
Endogenous Transplantedf
Endogenous
c
   
C
D
11
c+
 a
re
a 
[%
]
Cortex CMJ Medulla
0
20
40
60
80
n.s.
n.s.
n.s.
Transplanted
0
2
4
6
8
10
Cortex CMJ Medulla
d
   
 P
EC
A
M
-1
+  
ar
ea
 [%
]
Endogenous
Transplanted
n.s.
n.s.n.s.
CMJ
Medulla
Cortex
CMJ
Cortex
Medulla
Medulla
Cortex
CMJ
CMJ
Cortex
Medulla
Endogenous Transplanted
0
200
400
600
800
D
is
ta
nc
e 
ca
ps
ul
e
to
 m
ed
ul
la
 [?
m
] ***
21% 90%
g h
e
0 20 40 60 80 100 120
       DC subsets [%]
Endogenous
thymus
Spleen
Transplanted
thymus
CD8?+ CD11b– DCs
pDCs
other DCs
CD8?– CD11b+ DCs
n.s.
Results 
50 
(lower panel, a, b).  (c, d) The percentage of CD11c and PECAM-1 signal above 
background of the representative anatomic region of transplanted and endogenous thymi 
was evaluated.  (e) Flow cytometric analysis of the DC subset composition in spleen, 
endogenous and transplanted thymus.  (f) CD4/CD8 profile of thymocytes in endogenous 
(left panel) and transplanted (right panel) thymi.  Representative FACS plots were gated on 
live, non-doublet cells. (g) The shortest distance between the capsule and medullas of 
transplanted and endogenous thymi was measured as depicted in (h, arrow).  Each symbol 
presents an individual animal.  Highlighted boxes and corresponding numbers indicate the 
animals and percentage of animals in which medullas were located within 200 µm below 
the capsule.  Each symbol represents one independent experiment.  (h) Schematic image 
of a thymus.  Shown are medullas (red), DCs (green) and the capsule (blue).  The arrow 
illustrates the shortest distance between medulla and capsule that was measured and 
graphed in (g).  n=3-27 mice per group, P values were calculated using one-way ANOVA 
(c-e) or two-tailed, unpaired Student’s t-test (g), ***P < 0.0001, n.s. non significant, shown 
are mean ± s.e.m., scale bar = 50 µm 
 
 
The thymus is a relatively opaque tissue when exposed to visible light or 
infrared excitation, thus, structures that are further than 200 µm below the 
surface are not visible by MPM.  The medulla of endogenous six- to twelve-
week old mice was located 380 ± 37 µm below the surface and thus cannot 
be visualized by MPM (Fig. 11g).  Only 21% of endogenous thymi had 
medullas that are within 200 µm of the capsule.  We found that medullas of 
transplanted thymi are on average more superficial and only 128 ± 21 µm 
below the surface and that 90% of the transplanted thymi had medullas that 
are within range that is readily accessible to MPM (Fig. 11g, h).  This was 
most likely due to the overall smaller size of the transplanted thymus.   
 
Dendritic cell trafficking to transplanted thymi 
 
It has been shown previously that fully differentiated immature circulating DCs 
can gain access to the thymus from the blood by employing a multi-step 
adhesion cascade83.  Rolling is mediated by PSGL-1 –P-selectin and VLA4 – 
VCAM-1 interactions, and at least one yet unidentified chemoattractant that 
signals through Gαi-coupled receptors are required for firm arrest.  Maturation 
of DCs greatly reduces their ability to home to the thymus83.  Here, we asked 
whether the same mechanism that grants circulating DCs access to 
endogenous thymi also allows them to enter transplanted thymi.  To address 
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whether mature DCs home less efficiently to the transplanted thymus, splenic 
DCs, left untreated or matured overnight with LPS, were differentially labeled 
and injected intravenously.  Analysis of spleen, endogenous and transplanted 
thymi two hours later revealed that immature DCs readily accessed 
transplanted and endogenous thymi, while the homing capacity of mature 
DCs was impaired.  It is noteworthy that both mature and immature DCs could 
enter the spleen (Fig. 12a).  Pretreatment of immature DCs with Bordetella 
pertussis toxin (PTX) or treatment with non-depleting anti α4 mAb significantly 
and equivalently reduced the homing efficiency of DCs to endogenous and 
transplanted thymi but not spleen (Fig. 12b, c).  Likewise, pretreatment of 
mice with blocking mAbs to P-selectin and VCAM-1 interfered with the ability 
of DCs to accumulate in endogenous and transplanted thymi, but not spleen 
(Fig. 12d, e).   
 
Fig. 12.  Adoptively transferred immature DCs employ the same multi-step 
adhesion cascade to home to transplanted and endogenous thymi.  (a-c) For 
competitive homing assays, immature and either LPS maturated (a), PTX (b) or 
anti-α4 mAb (c) treated DCs, respectively, were differentially labeled and 
transferred intravenously into recipient mice. 18 hrs later, mice were sacrificed and 
homing indices were determined by dividing the percentage of homed, pretreated 
DCs by the percentage of non-treated DCs for spleen, endogenous and 
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transplanted thymi.  (d, e) To test the role of P-selectin and VCAM-1 in DC homing 
to the thymus, mice were treated with blocking mAbs or left untreated before DC 
transfer and homing was evaluated two hours later.  Pooled data from up to five 
independent experiments, n = 3-7 mice per group. Shown are mean ± s.e.m.; n.s. 
non significant, ***P < 0.0001, **P < 0.01, *P < 0.05; data were analyzed using one 
way ANOVA 
 
Taken together, our results demonstrate that immature, but not mature DCs 
readily access both transplanted and endogenous thymi via the same tissue 
specific multi-step adhesion cascade:  Rolling is mediated by endothelial P-
selectin interacting with glycosylated DC-expressed ligands, most likely 
PSGL-183.  At least one yet unidentified chemoattractant that signals through 
Gαi-coupled receptors is required for firm arrest, which is mediated by 
integrins, including DC expressed VLA-4 binding to VCAM-1, an IgSF 
member that is constitutively expressed in thymic microvessels.   
It has been reported previously that all DC subsets that can be isolated from 
spleens of donor animals enter the thymus with similar efficiencies83.  The 
subset composition of thymic DCs differs from that of splenic DCs that were 
transferred in homing experiments (Fig. 11e) and the finding that all DCs 
home equally well to the thymus has been challenged recently by a study that 
suggested that CD8α– and pDCs but not CD8α+ DCs readily home to the 
thymus in the steady state80.  We found that the composition of transferred 
DCs that can be recovered from thymi varies with the time interval that passes 
after adoptive transfer.  All splenic DC subsets from Flt3L-treated mice homed 
equally well to the thymus at two hours after adoptive transfer, consistent with 
earlier studies83.  However, the homed DC subsets were differentially retained 
in the organ or had different survival, especially pDCs and CD8α+11b– DCs, 
which were enriched at 18 hours compared to the input population.  At this 
time the subset composition began to resemble the endogenous thymic DC 
pool (Fig. 13).  These observation reconcile the apparent differences between 
previous studies, which are most likely due to differential retention or survival 
of homed DCs rather than preferential homing of specific DC subsets per se.   
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Fig. 13.  Phenotype of thymus 
homing DCs.  Splenic DCs were 
fluorescently labeled and 
injected intravenously into 
recipient mice.  At two and 18 
hours post inject, thymi were 
harvested and DCs subset 
composition was evaluated.  n = 
five-ten animals, P values were 
calculated by two-way ANOVA.  
***P < 0.001, *P < 0.05, n.s. non 
significant, shown are mean ± 
s.e.m. 
 
 
Subaim 1.2: To develop an imaging strategy to perform MP 
IVM of thymi 
 
In order to subject the transplanted thymi to MP IVM, the organs need to be 
surgically exposed and sufficiently immobilized as motion artifacts may render 
obtained imaging data uninterpretable.  In contrast to conventional IVM, which 
allows for real time recording, MPM relies on the acquisition at given time 
intervals (see also section “Multi-photon microscopy”).  A series of individual 
optical sections along the z-axis are taken at a given time interval.  The 
acquired z-stacks are then rendered into 3D volumes and played 250–300x 
accelerated over real time as a time-lapse movie (Fig. 14c).  Therefore, even 
subtle motion artifacts are exacerbated as the image stacks are recorded at 
time intervals rather than continuous real time acquisition and consequently, 
any motion artifacts will render the imaging data uninterpretable.   
The transplanted thymus was prepared as follows for MP IVM.  Transplanted 
animals were anesthetized by intraperitoneal (i.p.) injection of 150 – 200 µl of 
a combination of Ketamine HCl (100 mg/kg), Xylazine (10 mg/kg) and 
Acepromazine (3 mg/kg).  The mice were shaved and residual hair was 
removed by application of nair. The dorsal skin was be prepared for surgery 
by three applications of Betadine and 70% alcohol.  After verification of 
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adequate depth of anesthesia for surgery by checking the hind leg withdrawal 
and palpebral reflex, the thymus-bearing kidney of the anesthetized mouse 
was gently exposed as follows:  The skin was be opened with lateral with a 1 
– 1.5 cm dorsal incision. The retro-peritoneum was bluntly dissected from the 
skin and opened with a small 1 cm incision.  The kidney was gently 
exteriorized and fixed on a small styrofoam platform with two 27G1/2 needles 
that were placed above and below the transplant, as distal as possible.  The 
exposed organ was then embedded in ring vacuum grease that was filled with 
PBS to prevent drying out of the organ and a temperature probe was placed 
in physical contact with the kidney/thymus to constantly measure the 
temperature.  Next, a glass cover slip that was attached to an x-y-z–positioner 
was placed on top of the thymus to avoid potential drifts along the z-axis.  To 
keep the temperature at physiological range (37-39°C), a heating coil was 
placed on top of the cover slip (Fig. 14a, b).  This system allowed us to 
successfully subject the thymus to MP IVM, however, it is sensitive to motion 
artifacts that may originate from respiration and heart beat (through the renal 
artery).  Furthermore, the immobilization of the organ may cause hypoxia and 
stasis due to mechanical stress on the kidney’s vascular stem causing poor 
blood circulation.  The thymus is also a relatively opaque and densely packed 
tissue.  Hence it requires high laser powers to obtain images of regions that 
are deep within the tissue such as the medulla, which can cause photo 
bleaching and tissue damage.   
MPM was performed on a Prairie system at an excitation wavelength of 850 
nm, from a tunable MaiTai Ti:sapphire laser (Spectra-Physics, see also 
“Materials and methods”).  In order to collect 4D time-lapse recordings, stacks 
of optical sections of a region of interest were acquired at a pre-determined 
time interval.  To acquire z-stacks, optical sections were taken at vertical step 
intervals of 3 µm, using a 20x water immerse lens (20/×0.95 numerical 
aperture water-immersion objective lens, Olympus).  The collected data was 
then rendered into a 4D movie by converting individual z-stacks into 3D 
volumes using the imaging processing programs such as Volocity (Perkin 
Elmer) and Imaris (Bitplane).  The individual 3D volumes were then converted 
into a QuickTime movie and typically played at a 250–300x accelerated speed 
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for presentation purposes.  Image processing software was also used to 
identify single cells and track the movement of their centroids.  The data was 
then exported and analyzed with programs such as MatLab, Excel and Prism 
(Fig. 14c).   
 
Fig. 14.  Schematic presentation of the experimental set-up.  (a) To perform MP IVM of 
transplanted thymi, timed pregnancies were set up and pregnant mice were sacrificed at 
gestation day E14.5-18.5.  Thymi of the embryos were harvested and grafted 
immediately under the left kidney capsule of four-week old, male recipient mice.  (b) Four 
weeks later, the transplanted animals were subjected to MP IVM.  To do so, the left 
thymus-baring kidney of anesthetized mice was gently exposed, placed on a styrofoam 
platform and fixed to the platform with two 27G1/2 needles that were placed above and 
below the transplant, as distal as possible.  In some experiments, the organ was 
additionally fixed to the platform by applying tissue glue.  The exposed kidney/thymus 
was embedded in vacuum grease and PBS.  A cover slip, that was attached to an x-y-z–
positioner was placed on top of the thymus for further stabilization.  Lastly, a heating coil 
was added and a temperature probe was inserted to keep the preparation at 
physiological temperatures.  (c) For MP IVM, stacks of optical sections along the z-axis 
were acquired.  Image acquisition of z-stacks was continuously repeated over a certain 
time period at a given time interval.  Each z-stack was subsequently processed by image 
analysis software and rendered as a 3D volume.  Movies were generated by playing 
individual 3D volumes at a 250–300x accelerated speed over real time.  Using image 
analysis software, single cells were identified and their migratory path was tracked.  
Single cell tracks were then further analyzed and mobility parameters were extracted.   
 
Taken together, we have demonstrated in aim 1 that transplanted embryonic 
thymus lobes faithfully mirror their endogenous counterpart in terms of cellular 
composition and architecture.  Specifically, we have shown that the 
transplants are fully vascularized as early as four weeks after transplantation; 
they support T cell development and form cortical and medullary regions.  
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Medullas of transplanted thymi are located more superficially as compared to 
endogenous thoracic thymi.  This is most likely due to the smaller overall size 
of the transplant (unpublished observation).  We have shown that DCs 
localize to their respective anatomical location within the transplant and that 
their subset composition is essentially indistinguishable from thymic DCs of 
endogenous thymi.  Furthermore, we have successfully designed a surgical 
stage that allowed us to expose and sufficiently immobilize transplanted thymi 
in order to perform time lapse MP IVM.  MP IVM experiments of the following 
aims were based on the herein established system. 
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Aim 2: To analyze the motile behavior of thymic DCs and T 
cells 
 
Subaim: 2.1 To differentiate between cortex and medulla in 
vivo 
 
In order to observe the motile behavior of cells relative to immotile structural 
elements within the thymic cortex and medulla, it is indispensable to delineate 
them in vivo.   
We found that thymic medullas could be specifically visualized in vivo by i.v. 
injection of 20 µg of the TRITC labeled lectin UEA-1, which specifically binds 
to mTECs, 18 hours before analysis by MPM (Fig. 15a).  The binding of UEA-
1 in vivo was specific as confirmed by immunofluorescence analysis.  Briefly, 
cryosections of transplanted UEA-1 injected thymi were ex vivo stained with 
cytokeratin 8 mAb to delineate medulla and cortex and UEA-1 that was 
conjugated to a different fluorescent molecule to verify the specificity of the 
staining and analyzed by confocal microscopy (Fig. 15b).  Using this 
technique to label medullas in vivo, we identified the localization of homed 
DCs in the thymus.  We found that homed DCs colocalized with UEA-1+ 
medullas and were enriched at the cortico-medullary junction while they were 
sparse in the cortex.  The shape of the cells suggested that they had left the 
vasculature and were located within the thymic stroma (Fig 15a).  This was in 
good agreement with previously published data83.   
In the presence of TCR tg thymocytes, cortex and medulla were identified by 
the relative enrichment of tg T cells in the medulla.  TCR tg T cells express a 
pre-rearranged TCR and thus, RAG gene and TCR dependent steps of T cell 
development are accelerated in these animals, which leads to a significant 
enrichment of tg T cells in the medulla as compared to the cortex189 (Fig. 15c, 
d).   
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Fig. 15.  In vivo differentiation of cortex and medulla.  (a) Representative image 
from a MP IVM time-lapse recording of a transplanted thymus.  18 hours before 
imaging, UEA-1-TRITC and 2 × 106 splenic DCs from Actin-GFP donors were given 
i.v.  Shown are medullas (red) and homed DCs (green).  Scale bar is 100 µm (b) 
Representative confocal micrograph of a transplanted thymus.  The transplanted 
animal was injected with 20 µ g UEA-1-TRITC (red) i.v. and sacrificed 18 hours 
later.  The thymus was harvested and cryosections were performed and stained 
with anti cytokeratin 8 mAb (green, cortex) and Alexa 647 labeled UEA-1 (blue, ex 
vivo, medulla).  Scale bar is 50 µ m. (c) Representative image from MP IVM 
recordings of transplanted thymi of animals that were sublethally irradiated and 
reconstitute with 107 BM cells from OT-I TCR tg × T-red donors.  MP IVM was 
performed four weeks after BM transplantation.  Denoted are cortex, medulla and 
kidney.  Shown are TCR tg thymocytes (red); the vasculature was highlighted by 
the injection of high molecular weight FITC/TRITC-dextran (yellow); the kidney was 
identified by second harmonic signal (blue).  Scale bar is 100 µm.  (d) Evaluation of 
numbers of TCR tg thymocytes per mm3 in cortex and medulla as shown in (c).  
Each symbol pair represents one independent experiment.  Two-tailed, paired 
Student’s t-test, *P < 0.05.  
 
As thymocytes are highly proliferative, they are not suitable for ex vivo 
labeling before adoptive transfer and instead, require a genetically encoded 
label.  Therefore, we generated BM chimeric animals by injecting tg BM from 
either T-red tg or DPE-GFP tg animals that were crossed on a TCR tg 
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background into sublethally irradiated, transplanted recipient mice.  T-red and 
DPE-GFP animals express dsRed or GFP, respectively, under the CD4 
promoter; hence, all T cells in these mice are fluorescently tagged and can be 
detected by MPM190.  In this study, OT-I and P14 tg BM were used.  OT-I tg T 
cells recognize the ovalbumin derived peptide SIINFEKL in the context of H-
2Kb 191; P14 tg T cells are specific for the LCMV glycoprotein derived peptide 
KAVYNFATC (gp33–41) in the context of H-2Db 192.  The half-lives of 
SIINFEKL and gp33 on MHCI have been determined to be 31-44 hours (for 
SIINFEKL)193 and 2.4 hours (for gp33)194. 
Cortex and medulla were differentiated as follows in the presence of 
fluorescently tagged TCR tg thymocytes:  We delineated cortex and medulla 
after visual inspection of MPM images and determined the number of tg 
thymocytes per mm3 using Imaris software.  As TCR tg thymocytes 
prematurely express a fully functionally TCR, their RAG dependent 
development is accelerated and thus, TCR tg thymocytes specifically 
accumulate in the medulla189.  In agreement with this, we found that there was 
a significant 2.5-fold ± 0.54 enrichment of TCR tg thymocytes in the medulla 
versus the cortex (*P < 0.05, Fig. 15c, d).  Thus, the relative abundance of 
TCR tg thymocytes in the medulla can be used as a surrogate marker to 
differentiate between cortex and medulla in vivo.   
Please note that we used the herein described methods to delineate cortex 
and medulla in vivo in all consecutive experiments.   
 
Subaim 2.2: To analyze DC and thymocyte motility in cortex 
and medulla 
 
Next, we sought to investigate the motile behavior of thymocytes and DCs 
that had homed to the thymus in cortex and medulla.   
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Fig. 16.  Motility of thymic homed DCs two hours after transfer and thymocytes in 
cortex and medulla.  Mean displacement plots (left panel), frequency histograms of 
3DIV (middle panel) and mean velocity per track (right panel) of DCs in medulla 
and CMJ (a), cortical (b) and medullary OT-I TCR tg thymocytes (c).  The straight 
line in the mean displacement plots (left panel, red) denotes the regression function 
of the initial linear segment of the curve.  The motility coefficients M were calculated 
from the slope of the regression line and are depicted in the respective graphs.  
Color-coded arrows in the frequency histograms (middle and right panel) highlight 
the population’s median.  Gray bars (a, middle and right panel) indicate the 3DIV 
(middle panel) and mean velocity per track (right panel) of auto-fluorescent, 
immobile background structures.  P values were calculated using Mann-Whitney U-
Test, ***P < 0.0001  
 
Cortex and medulla were identified by injection of fluorescently labeled UEA-1 
or the relative accumulation of TCR tg thymocytes in the medulla, respectively 
(subaim 2.1).  18 hours after entering the thymus, homed DCs in medulla and 
cortico-medullar junction migrated randomly as determined by plotting the 
cells’ mean displacement versus the square root of time (Fig. 16a, left panel, 
see also “Multi-photon microscopy” section).  As compared to OT-I tg 
thymocytes in cortex and medulla, DCs move at a significantly lower 3D 
instantaneous velocity (3DIV, mean ± s.e.m. 4.0 ± 0.05 µm/min, median 3.2 
µm/min, P < 0.0001) and mean velocity per track (mean ± s.e.m. 4.9 ± 0.16 
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µm/min, median 4.7 µm/min, P < 0.0001).  The measured velocities did not 
result from insufficient immobilization of the thymus as determined by tracking 
of immobile auto-fluorescent structures in the same imaging volume (3DIV 
mean ± s.e.m. 2.1 ± 0.03 µm/min, median 1.7 µm/min, P < 0.0001; mean 
velocity per track mean ± s.e.m. 3.1 ± 0.08 µm/min, median 2.9 µm/min, P < 
0.0001) (Fig. 16a, middle and right panel, Table 4).  It is noteworthy that 
tracks of fast moving cells are prone to being split up into several smaller 
tracks, which results in their over-representation and accounts for the 
generally higher mean velocities per track as compared to 3DIV, which 
weights each cell’s displacement between frames equally (see also “Multi-
photon microscopy” section).   
 
Table 4. Thymocyte and DCs motilities in the steady state 
3D instantaneous velocity 
[µm/min] 
Mean velocity per track 
[µm/min] Cell type 
mean ± s.e.m. median mean ± s.e.m. median 
Homed DCs 4.0 ± 0.05 3.2 4.9 ± 0.16 4.7 
Cortical 
thymocytes 8.7 ± 0.03 5.8 9.2 ± 0.21 8.0 
Medullary 
thymocytes 11.9 ± 0.07 8.6 15.0 ± 0.20 14.6 
 
In contrast to DCs, OT-I transgenic thymocytes displayed higher velocities 
and migrated in a more confined pattern (Fig. 16b, c).  Medullary TCR tg 
thymocytes (3DIV mean ± s.e.m. 11.9 ± 0.07 µm/min, median 8.6 µm/min, 
median velocity per track 15.0 ± 0.20 µm/min, median 14.6 µm/min) migrated 
with significantly higher 3DIV and mean velocities per track than cortical 
thymocytes (3DIV mean ± s.e.m. 8.7 ± 0.03 µm/min, median 5.8 µm/min, P < 
0.0001; mean velocity per track 9.2 ± 0.21 µ m/min, P < 0.0001) in the 
absence of cognate Ag, which was in agreement with data obtained from in 
vitro systems186 (Fig. 16b, c, middle panel, Table 4).  Despite their higher 
velocity, medullary thymocytes scanned a smaller volume than cortical 
thymocytes, which was reflected by a lower motility coefficient (41.11 µm2/min 
versus 33.40  µm2/min) (Fig. 16b, c, left panel).  This likely reflects the 
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sampling behavior of OT-I TCR tg thymocytes in the process of negative 
selection.  We suggest that TCR tg thymocytes continuously scan APCs in the 
thymic medulla, which is reflected by relatively high velocities but confined 
migration patterns with low motility coefficients (Fig. 16c).  Conversely, we 
hypothesize that thymocytes that encounter cognate Ag in the medulla 
engage in prolonged cognate interactions, which would result in lower 
velocities and even more confined migration patterns. 
 
Subaim 2.3: To analyze the effect of cognate Ag on thymocyte 
behavior 
 
In order to observe potential DC – thymocyte interactions in vivo, transplanted 
animals were sublethally irradiated and reconstituted with either OT-I × T-red 
TCR tg BM alone or a mixture of OT-I × DPE-GFP and P14 × T-red TCR tg 
BM.  This protocol usually results in 10-15% TCR tg thymocytes.  Three to 
four weeks after BM transplantation, 5 × 106 purified splenic DCs that were 
either labeled with CMAC or harvested from Actin-GFP donors were pulsed 
with 1 µM of the ovalbumin-derived peptide SIINFEKL and given i.v..  MP IVM 
was performed 18 hours later (Fig. 17a).  The concentration used to pulse 
DCs was in the linear part of the loading curve and thus non-saturating (Fig. 
17b).  It is of note that at the time Ag pulsed DCs were given, TCR tg T cells 
can be detected in LNs, albeit at small numbers (<5%).  Activation of 
peripheral T cells can lead to a cytokine storm that induces non-specific T cell 
apoptosis in the thymus87.  If this was the case, administration of SIINFEKL 
pulsed DCs would not only affect specific OT-I TCR tg thymocytes but also 
non-specific P14 TCR tg thymocytes.  However, this was not observed with 
this protocol due to the small number of peripheral specific T cells.  Specific 
OT-I TCR tg but not non-specific P14 TCR tg thymocytes showed a 
remarkable change in motile behavior in the presence of SIINFEKL pulsed 
DCs.  OT-I TCR tg thymocytes migrated significantly slower (3DIV mean ± 
s.e.m. 4.5 ± 0.07 µm/min, median 3.0 µm/min; mean velocity per track 9.0 ± 
Results 
63 
0.24 µm/min, median 7.2 µm/min) as compared to non-specific P14 TCR tg T 
cells in the same imaging volume (3DIV mean ± s.e.m. 11.0 ± 0.16 µm/min, 
median 9.0 µm/min, P < 0.0001; mean velocity per track 14.0 ± 0.35 µm/min, 
median 13.9 µ m/min, P < 0.0001) and OT-I TCR tg thymocytes in the 
absence of cognate Ag (Fig. 17d, e and Fig. 16c).  We also noted that Ag 
specific T cells were more confined in their migration pattern and scanned a 
smaller volume as reflected by the mean displacement graph and the lower 
motility coefficient (motility coefficient of non-specific P14 thymocytes was 
49.04 µm 2/min vs. 26.37 µm2/min for Ag specific OT-I TCR tg T cells, Fig. 
17c).  This differential Ag-driven behavior would presumably allow the T cells 
to engage in prolonged interactions with Ag pulsed DCs.  Indeed non-specific 
thymocytes only occasionally interacted with DCs and these interactions were 
short in nature (mean ± s.e.m. 3.7 ± 0.7 min, median 2.3 min).  In contrast, Ag 
specific thymocytes formed much longer contacts (mean ± s.e.m. 18.7 ± 4.0 
min, median 5.9 min, P = 0.0049).  18% of Ag specific thymocytes were 
interacting with Ag pulsed DCs throughout the entire imaging period of 60 
minutes, and 24% for at least 30 minutes, which has been reported to be the 
minimal amount of time needed to form a mature immunological synapse 
between fully mature T cells and antigen presenting cells195 (Fig. 17f, g).  
Notably, not all TCR tg specific thymocytes in the medulla engaged in 
prolonged contacts with peptide pulsed DCs.  CLPs that have entered the 
thymus are de-synchronized during T cell development, which leads to a 
heterogeneous T cell population in the medulla.  Because of this, it is not 
surprising that not all TCR tg thymocytes were interacting with Ag pulsed DCs 
as they were probably to be at different stages in their development.   
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Fig. 17. Effects of cognate Ag on thymocyte behavior.  (a) Schematic of the 
experimental protocol.  Embryonic thymus lobes were transplanted under the kidney 
capsule of 4-6 week old recipient mice.  Animals were sublethally irradiated and 
reconstitute with BM from TCR tg donor mice at least one week after transplantation.  
Four weeks later, splenic immature DCs that were pulsed with 1 µm SIINFEKL, were 
given i.v. and animals were subjected to MP IVM 18 hours later.  (b) Loading curve 
of DCs that were pulsed with the indicated concentrations of SIINFEKL peptide and 
analyzed by flow cytometry.  (c) Mean displacement plots of specific (blue) and non-
specific thymocytes (red) with color-coded regression function of the initial linear 
segment of the curve.  The motility coefficient of specific and non-specific 
thymocytes is depicted in the graph.  (d, e) Frequency histograms of 3DIV (d) and 
mean velocity per track (e) of OT-I TCR tg specific (blue) or P14 TCR tg non-specific 
(red) thymocytes.  Color-coded arrows indicate the population’s median.  (f) 
Absolute contact duration between T cells and DCs in the presence and absence of 
Ag.  Mann-Whitney U-Test (d-f), **P = 0.0049, ***P < 0.0001.  (g) Representative, 
surface rendered MPM image.  Shown are SIINFEKL pulsed DCs (green) and OT-I 
× T-red tg thymocytes (red), scale bar is 5 µm  
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Interestingly, the interactions times of OT-I tg thymocytes with Ag pulsed DCs 
(18.7 ± 4 minutes) greatly exceeded those that have been reported previously 
for OT-I thymocytes by Le Borgne et al186 (1.9 minutes).  However, one must 
keep in mind that the latter study utilized RIPm-OVA mice, which express 
membrane bound ovalbumin (mOVA) under the control of the rat insulin 
promoter (RIP), which is also active in mTECs but not DCs.  Nevertheless, the 
interaction time was measured between thymocytes and DCs, which can gain 
access to ovalbumin derived peptides via mechanisms such as cross 
presentation75.  Presumably, the Ag concentration on the DCs differs in these 
different systems and could account for the apparent discrepancies.  Another 
possible explanation for the differences between the two data sets may lie in 
the expression of ovalbumin in mTECs in RIPm-OVA mice.  It is possible that 
thymocytes preferentially interact with mTECs rather than DCs in this system, 
and hence the relevant interaction to evaluate would have been between 
mTECs and thymocytes.  Indeed, the authors notice that OT-I T cells migrate 
in “confinement zones”, as they seem to stay in the proximity of Ag bearing 
DCs186.  Alternatively, this phenomenon can be explained by the interaction of 
specific T cells with Ag presenting mTECs.  Thus, OT-I cells appear to 
migrate in a confined zone, while in fact, they may be interacting locally with 
unlabeled mTECs.   
Taken together, we have shown that thymocytes are highly motile in vivo but 
change this behavior in the presence of cognate Ag.  When Ag is presented 
by homed DCs, specific but not non-specific thymocytes engage in prolonged 
interactions with DCs.  It is tempting to speculate that cognate prolonged 
interactions are not restricted to T cell – DC interactions but can also occur 
between thymocytes and other antigen presenting cells, such as mTECs.  
Indeed, indirect evidence for this has been provided by Le Borgne et al., 
however, further experiments that specifically evaluate these interactions will 
be required to draw any conclusions on this matter.   
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Aim 3: To analyze homed vs. thymus resident DCs 
 
We have established in subaim 2.2 that homed DCs are motile and display a 
random walk behavior.  It is possible that this migratory behavior helps them 
to present their acquired Ag to a maximal number of developing thymocytes.  
Thus, the function of homed DCs is not only limited to the delivery of 
peripheral Ag to the thymus, they also present the Ag and induce negative 
selection83.  Indeed, MHC-II deficient but not sufficient homed DCs that have 
phagocytosed cognate Ag, failed to induce negative selection of specific 
thymocytes83, which indicates that homed DCs present Ag rather than 
disseminating it to resident APCs for presentation purposes.  We have also 
shown in vivo that homed Ag pulsed DCs engage in long-lived interactions 
with Ag specific thymocytes (subaim 2.3), providing further evidence that 
homed DCs play an important role in Ag presentation in the thymus.   
In LNs, freshly homed DCs display a motile behavior which peaks at about 24 
hours post transfer and then decreases with time133.  Our aim was to address 
the motility of thymic DCs by comparing freshly homed thymic DCs to thymus 
resident DCs.  We generated BM chimeric animals by lethally irradiating wt 
recipient mice and reconstituting them with BM from CD11c-YFP donor mice.  
CD11c-YFP animals express a fluorescent protein under the control of the 
CD11c promoter.  The bulk of thymic DCs expresses YFP in these animals 
and can be easily identified by MPM126.  BM chimeric animals were grafted 
with embryonic thymi and were rested for four weeks before intravenous 
injection of fluorescently labeled DCs.  Two hours post DC transfer, the 
animals were subjected to MP IVM (Fig. 18a).  At this time point, homed DCs 
could be readily detected in the thymus.  Image analysis revealed that they 
moved with higher 3DIV and mean velocities per track as compared to 
endogenous, resident DCs (Fig. 18b, Table 5).  Analysis of the migration 
patterns showed that homed DCs followed a more directional path, which was 
reflected by a higher meandering index (Fig. 18c).  In agreement with this, 
they covered a greater volume, resulting in a higher motility coefficient as 
compared to thymus resident DCs (Fig. 18d).  Homed and thymus resident 
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DCs also showed remarkable differences in shape.  While homed DCs 
typically were more round and compactly shaped, resident DCs were spread 
out, with dendrites, and were often found in close association with capillaries 
(Fig. 18e).   
 
 
Fig. 18.  Thymus resident DCs exhibit a lower motility than homed DCs.  (a) 
Diagrammatic representation of experimental protocol.  Thymus resident and homed 
thymic DCs were visualized in transplanted thymi by employing MP IVM. Briefly, 
transplanted recipient mice were lethally irradiated, reconstituted with CD11c-eYFP BM 
and rested for four weeks.  Two hours before imaging, fluorescently labeled DCs were 
given i.v.  (b-d) Shown are frequency distribution histograms of the 3DIV (b) and 
meandering index (c) of homed (blue) and resident DCs (green) as well as the motility 
coefficients (d).  Color-coded arrows highlight the population’s median (b, c).  The 
meandering index is calculated by dividing each cell’s absolute displacement by the 
length of the path.  Data were pooled from four experiments (b-d).  P values were 
calculated using Mann-Whitney U-Test (b) and two-tailed, unpaired Student’s t-test (c, 
d) respectively. (e) Resident DCs are frequently found in close association with 
capillaries (arrows). Representative image shows blood vessels (red), resident DCs 
(green), homed DCs (blue) and auto-fluorescent structures (magenta).  Scale bar = 50 
µm. 
 
Cumulatively this data indicate that two hours after adoptive transfer homed 
DCs are motile while resident DCs display a more sessile behavior.  
Interestingly, homed DCs move significantly slower 18 hours post adoptive 
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transfer as compared to two hours after i.v. injection as reflected by their 
mean and median 3DIVs (P < 0.0001, Table 5, Fig. 19a).  At this time point 
the migration speed approximates the one of resident DCs.  It is of note that 
these DCs also migrated statistically significantly slower than resident DCs (P 
< 0.0001, Table 5, Fig. 19b).  Interestingly, this difference seems less 
pronounced when comparing the medians of the two populations (3DIV 
median for endogenous DCs 3.35 µm/min versus 3DIV median of 18 hours 
homed 3.2 µm/min)  rather than the mean (Table 5).  The median as 
compared to the mean is less affected by outliers of the data sets.  Visual 
inspection of the frequency distribution histograms further supports the notion 
that the median is more representative of the population’s behavior than the 
mean (Fig. 19a, b).  The difference in the mean, and the less pronounced 
difference in the median is most likely caused by the comparison of DC 
populations in different mice.  While the migratory behavior of resident and 
homed DCs two hours post transfer was addressed in the same imaging 
volume, data for DCs that have homed for 18 hours were derived from 
separate animals.  Small differences, especially of slow moving cells, are 
likely caused by the preparation of different animals for MP IVM.   
 
Fig. 19.  Velocity of homed 
DCs decreases with time.  
Shown are frequency 
distribution histograms of 
the 3DIV of endogenous 
DCs versus homed DCs 
two hours (a) or 18 hours 
(b) post transfer.  Color-
coded arrows and 
numbers highlight the 
population’s median.  P 
values were calculated 
using Mann-Whiney U-
Test, ***P < 0.0001 
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Table 5. Velocity of thymic DCs 
3D instantaneous velocity 
[µm/min] Cell type 
mean ± s.e.m. median 
Endogenous DCs 5.07 ± 0.03 3.35 
Homed DCs 
2 hours 5.68 ± 0.07 4.15 
Homed DCs 
18 hours 4.0 ± 0.05 3.2 
 
Thus, DCs move 18 hours post transfer significantly slower than two hours 
post transfer.  Their migration speed approximates that of endogenous DCs at 
this time point.  This is particularly interesting as the DCs subset composition 
at two and 18 hours post transfer differs significantly .  At earlier time points, 
CD8α+11b– DCs are greatly overrepresented as compared to the endogenous 
DC pool.  With time, the subset composition of homed DCs changes and at 18 
hours post transfer, it grossly resembles the endogenous DC pool (Fig. 13).  
Hence, the difference in the subset composition could potentially account for 
the differences in speed.  Therefore one has to assume that different DC 
subsets display different motile behaviors, which may be reflective of specific 
functional specializations.  However, MP IVM analysis of different DC subsets 
is required to investigate these possibilities in depth.   
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Aim 4:      To test whether thymus resident DCs acquire blood 
borne Ag 
 
Subaim 4.1: To test whether thymic DCs can sample the blood 
 
Thymic DCs play an important role in central tolerance induction by 
presenting self-peptides to thymocytes (see also section “T cell development” 
and “Thymic antigen presenting cells in positive and negative selection”).  
There are three known ways how thymic DCs can gain access to peptides for 
presentation during central tolerance:  (1) They can generate peptides 
themselves by protein degradation, (2) acquire them from mTECs that 
expressed self-proteins by PGE, (3) or peripheral thymus-bound DCs can pick 
up self-proteins or commensal proteins in the periphery and transport it to the 
thymus as their cargo.  As we observed that thymus resident DCs were often 
closely associated with capillaries (aim 3, Fig. 18e and Fig. 20a-c), we 
hypothesize that there could be a forth way for thymic DCs to gain access to 
self-proteins and / or commensal proteins that are not expressed in the 
thymus per se.  We hypothesized that capillary-associated DCs could breach 
the endothelial layer and extend protrusions into the blood.  This could be a 
previously unrecognized mechanism through which thymic DCs could to 
potentially pick up blood borne Ag and make it available for T cell selection.   
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Fig. 20.  Thymus resident DCs can be found in close association with capillaries.  
Representative immunofluorescence of a thymus that was grafted under the kidney 
capsule of a CD11c-YFP transgenic animal.  Shown are a z-series  (a, panel 1-9) and 
zx- and zy-side views (b) as well as a surface rendered illustration (c) of a 
representative DC (green) that is closely associated with a capillary (red).  Step size 
is 2 µm; scale bars are 10 µm. 
 
As DCs that breach the endothelial layer would be at least partially exposed to 
the blood, we designed an approach to specifically label these intravascular 
parts of DCs.  To do so, we injected intravenously an anti CD11c mAb that 
was conjugated to phycoerythrin (PE).  PE is relatively large fluorescent 
molecule (MW 240 kDa) and when conjugated to Abs it hinders them from 
passing through the endothelium18,196.  Thus, intravenously injected PE-
conjugated Abs can only stain structures that are within the vasculature.  We 
hypothesize that DCs that extend protrusions into the blood as well as fully 
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intravascular DCs can be stained by i.v. injection of anti CD11c-PE mAbs, 
while DCs that are truly located within the thymic stroma cannot be labeled 
with this method (Fig. 21a).  It is noteworthy that this method will not allow for 
differentiation between DCs that are in the process if immigrating / emigrating 
to / from the thymus and DCs that are strategically positioned in close 
association with blood vessels to potentially sample the blood for Ag (Fig 
21b).   
We named DCs that can breach the endothelial layer and are therefore 
located in both compartments, the thymic stroma and the vasculature, 
transendothelial (TE-) DCs.  
 
Fig. 21.  Schematic of TE-DCs.  (a) DCs that are exposed to the blood can be 
stained with an intravenously administered PE-labeled Ab.  The staining intensity of 
the PE-label is likely to be proportional to the fraction of the DC that is located 
intravascularly.   (b) Notably, TE-DCs may be a mixed population consisting of DCs 
that are in the process if immigrating/emigrating to/from the thymus and DCs that are 
sampling the blood potentially for antigenic material. 
 
 
As hypothesized, intravenous injection of anti CD11c-PE but not isotype-PE 
control Ab specifically stained a small but highly significant fraction of thymic 
DCs (0.05 ± 0.007 vs. 1.18 ± 0.09, P < 0.0001, Fig. 22a, b).  The thymi of 
four-week old male C57BL/6 mice consist of 210×106 ± 9.4×106 cells, of which 
230,000 ± 12,000 are DCs and further, 1,800 ± 620 DCs can be labeled 
intravascularly (Fig. 22c) indicating that these cells are at least partially 
exposed to the blood flow.  However, this approach does not allow for 
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differentiation between TE-DCs and entirely intravascular DCs (Fig. 21a).  To 
address whether intravenous anti CD11c-PE-labeling identifies TE-DCs, 
thymic DCs from animals that were injected with anti CD11c-PE or isotype-PE 
control Ab were isolated, fixed on poly-L-lysine slides and competitively 
stained with an anti CD11c mAb of the same clone but conjugated to a 
different fluorescent molecule.  We hypothesized that TE-DCs would be 
partially stained with the i.v. administered mAb and thus, epitopes that were 
not exposed to the blood would still be available for ex vivo staining, resulting 
in a polarized staining pattern.  As a control, DCs from isotype control injected 
animals were co-stained ex vivo with two preparations of CD11c mAbs of the 
same clone, but conjugated to different labels.  In this case, both mAbs should 
bind evenly to epitopes on the cells.  Indeed, the obtained results were in 
agreement with this hypothesis (Fig. 22d).   
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Fig. 22.  Identification of transendothelial, bi-compartmental, thymic DCs.  (a, b) Wild 
type animals were injected intravenously with anti CD11c-PE mAb or isotype-PE control 
mAb and sacrificed two minutes later, and single cell suspensions were stained ex vivo 
with a different clone of anti CD11c mAb.  PE+ thymic DCs were assessed by flow 
cytometry.  (a) Representative FACS plots were gated on total CD11c positive cells. (b) 
Analysis of (a), the percentage of PE+ cells was plotted.  (c) Enumeration of thymic 
cellularity of four-week-old male mice.  (d) Representative confocal images (upper 
panel) and surface rendered illustrations (lower panel) of DCs that were fixed on poly-L-
lysine coated slides from mice that were injected with anti CD11c-PE mAb (left panel) or 
isotype-PE control mAb (middle and right panel).  Slides were stained with anti CD11c-
Alexa 488 alone (left and middle panel) or a combination of anti CD11c-Alexa 488 and 
anti CD11c-Alexa 647 (right panel).  Shown are representative images of two 
independent experiments; scale bar is 10 µm.  (e) Mice were injected with anti CD45-PE 
mAb, sacrificed two minutes after injection, and single cell suspensions of thymi and 
blood were prepared and ex vivo stained with anti CD45.2 and anti CD11c mAbs and 
analyzed by flow cytometry.  Plotted are the percentage of DCs among total 
hematopoietic cells in blood and thymus as compared to the percentage of thymic DCs 
of PE+ hematopoietic cells in thymus.   (f) Percentage of PE+ splenic, thymic and LN 
DCs of animals that were injected with anti CD11c-PE or isotype-PE control mAb.  (g) 
Subset contribution of PE+ and PE– DCs in thymus and total DCs in LN and spleen of 
animals that were given anti CD11c-PE i.v.  Representative data from two-three 
independent experiments, each symbol presents an individual animal, n = three-nine 
mice per group per experiment; P values were calculated using two-tailed, unpaired 
Student’s t-test (b) or one-way ANOVA (c, e-g), ***P < 0.0001, **P < 0.001; shown are 
mean ± s.e.m.   
 
It is possible that PE+ DCs were not truly TE-DC but rather DCs that were 
located in the blood and were harvested with the organ.  The following 
experiment was designed to address this possibility:  C57Bl/6 mice were 
injected with anti CD45-PE mAb i.v. to label all vascular hematopoietic cells.  
The animals were sacrificed two minutes after Ab injection and blood and 
thymus were collected and ex vivo stained with anti CD45.2 mAb to identify all 
hematopoietic cells.  The percentage of DCs among all hematopoietic cells in 
blood and thymus was then compared to the percentage of DCs among the 
intravascular CD45-PE+ cells in thymus.  Notably, CD11c+ cells were 
significantly enriched in thymic, intravascular, hematopoietic population (13.9 
± 4.43 %) as compared to blood (0.4 ± 0.18 %, P < 0.05) and total thymic, 
hematopoietic cells (0.08 ± 0.003 %, P < 0.05).  This finding strongly suggests 
that intravascular DCs do not originate from potential contaminating blood as 
the percentage of PE+ DCs is significantly higher then the percentage of DCs 
in the blood or the whole thymus (Fig. 22e).   
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It is possible that thymic DCs were stained by free anti CD11c-PE Ab during 
the organ dissociation in the course of the DC preparation, even though the 
data obtained from the analysis of DCs that were fixed on poly-L-lysine slides 
suggested otherwise.  Staining with free anti CD11c-PE Ab during the 
preparation would have resulted in a homogenous staining of the cell surface 
rather than the observed “patchy” staining (Fig 22d).  However, to further 
evaluate this possibility, spleens, inguinal LNs and thymi of anti CD11c-PE 
injected animals were analyzed by FACS staining.  We hypothesize that the 
bulk of splenic DCs but very few to no LN DCs would acquire the label.  
Indeed, 70% of splenic DCs but only a small and, compared to isotype 
control, non-significant percentage of LN DCs could be labeled intravenously 
(Fig. 22f).   
Lastly, the subset composition of intravascularly stained thymic DCs differed 
greatly from the pool of total intrathymic DCs and resembled more closely the 
compositing of DC subsets that can be found inguinal LNs.  As compared to 
intrathymic DCs, CD11c+CD8α–CD11b+CD34intCD103– DCs were among 
intravascularly stained DCs, while pDCs and CD11c+CD8α+CD11b– DCs were 
underrepresented (Fig. 22g).  In the thymus and LNs, CD8α– DCs express 
the chemokine receptor CX3CR1.  The difference in the subset composition of 
intrathymic versus bi-compartmental, TE-DCs provides another clue that the 
latter cell population is not stained by intravascular Ab that is released during 
the cell preparation.  In this case one would expect a similar subset 
composition in both PE+ and PE– DC populations.   
Taken together, this data strongly suggests that a small percentage of thymic 
DCs have direct access to the blood.  It is unlikely that they stem from 
contaminating blood or are an artifact caused by free Ab that was released 
during the cell preparation.  These cells are likely to be bi-compartmental, 
transendothelial, as suggested by confocal microscopy, and are enriched in 
the CD11c+CD8α–CD11b+CD103– DC subset as compared to intrathymic 
DCs.   
At this point, the importance of thymic TE-DCs remains unknown.  We 
hypothesize that they extend protrusions into the bloodstream to acquire 
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circulating Ag and make it available for T cell selection.  However, it is also 
possible that TE-DCs include cells that were in the process of migrating in or 
out of the thymus at the time the mAb was given (Fig. 21b).  To address the 
latter possibility, we blocked DC homing by administration of a blocking mAb 
to α4-integrins.  Injection of the mAb one hour before i.v. administration of anti 
CD11c-PE did not affect the frequency of PE+ DCs in the thymus, indicating 
that TE-DCs are not immigrating cells and that further, α 4-integrin is 
dispensable for acquiring an transendothelial phenotype (Fig. 24a).   
We cannot rule out that TE-DCs are in the process of emigrating from the 
thymus into the blood.  However, such a migration pattern has not been 
described to date and furthermore, we have never observed DC emigration 
from the thymus MP IVM either.   
Future experiments will visualize the formation of transendothelial protrusions 
into the blood in vivo byMP IVM.  We aim to address the hypothesis that 
intravascular labeling of TE-DCs can be directly visualized in vivo.   
 
 
Subaim 4.2: To evaluate whether homed and thymus resident 
DCs can extend transendothelial protrusions 
 
Image analysis of capillary-associated DCs revealed that they were almost 
exclusively thymus resident DCs rather than homed DCs (Fig. 18e, 20a-c).  
To confirm this observation, immature DCs were isolated, fluorescently 
labeled, given intravenously to C57Bl/6 recipients, followed 18 hours later by 
i.v. injection of anti CD11c-PE.  In this setting, FACS analysis showed that 
transferred DCs were more abundantly stained with the intravascular Ab as 
compared to resident DCs (Fig 23a, c).  However, the mean fluorescence 
intensity (MFI) of homed PE+ DCs was significantly higher than the MFI of 
resident DCs (Fig. 23b, c).  These findings raised suspicion as to whether 
homed PE+ DCs were entirely intravascular rather than transendothelial (Fig. 
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22a).  As shown previously, TE-DCs are only partially exposed to the blood.  
Thus, the injected Ab cannot physically access all available CD11c epitopes 
of the cell (Fig. 21d).  Consequently, higher MFIs may indicate that cells were 
in fact fully intravascular.  Indeed, MP IVM revealed that homed DCs are 
frequently “stuck” in capillaries in the thymus at two and 18 hours post transfer 
(unpublished observation).  To experimentally address whether homed PEhigh 
cells are fully intravascular, the following experiment was designed.  CD57Bl/6 
mice were injected with immature DCs 18 hours before administration of anti 
CD11c-PE mAb (clone N418).  The animals were sacrificed; blood and thymi 
were collected and stained with anti CD11c mAb (clone HL3) to label all DCs 
and anti CD11c mAb (clone N418) as a competitive staining (Fig. 23d).  The 
rational is that the intravenously administrated Ab binds to most, if not all, 
epitopes of blood borne DCs, and thus, only a few epitopes are available for 
staining by the in vitro administrated identical Ab clone.  For intrathymic DCs, 
this scenario would be reversed.  If homed PEhigh cells are fully intravascular, 
then their staining pattern will be similar to that of blood derived DCs.  If they 
are bi-compartmental, then the ratio of i.v. versus ex vivo administrated Ab 
would be more similar to that of resident thymic PE+ DCs.  The results of this 
experiment suggested that adoptively transferred PE+ DCs are similar to 
blood borne DCs (Fig. 23e).  Thus, they are most likely not transendothelial 
but instead are fully intravascular.   
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Fig. 23.  Intravascular labeling of homed and endogenous thymic DCs.  (a, b) Recipient 
mice were injected with fluorescently labeled DCs 18 hrs before intravenous injection of 
CD11c-PE and were sacrificed two minutes later.  Single cell suspensions were 
analyzed by flow cytometry.  Plotted are the percentage (a) and the MFI (b) of homed 
versus endogenous PE+ DCs.  (c) Representative FACS plots were gated on total 
CD11c+ DCs.  (d) To determine whether homed PEhigh cells originate from blood 
contaminations, wild type animals were injected intravenously with anti CD11c-PE clone 
N418 and sacrificed two minutes later.  Single cells suspension were prepared and 
stained with anti CD11c clone N418 (competitive staining) and CD11c clone HL3 (to 
identify all CD11c+ cells).  Single cell suspensions were analyzed by gating on total 
intravascularly labeled endogenously, homed and blood DCs, respectively.  (e) The ratio 
of MFIs of in vivo and ex vivo Ab staining was calculated and normalized by the ratio of 
homed DCs.  Shown are the ratios of the MFIs of intravenously administered Ab (CD11c 
i.v.) / ex vivo administered Ab (CD11c ex.) for endogenous thymic, homed thymic and 
blood borne DCs.  Shown are representative data from two independent experiments, n 
= three-five mice per group per experiment; two-tailed, unpaired Student’s t-test; ***P < 
0.0001, **P < 0.01; shown are mean ± s.e.m. 
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Future experiments will aim to further our understanding of the bi-
compartmental distribution of homed and thymus resident DCs, by performing 
immunofluorescence and MP IVM.  This approach will allow us to address 
directly whether homed DCs contribute to the pool of transendothelial DCs 
and whether they exhibit a sampling phenotype or are simply caught during 
transendothelial migration. 
 
Subaim 4.3: To assess the mechanism by which 
transendothelial DCs gain access to the blood 
stream 
 
Next we asked by which mechanism DCs could extend transendothelial 
protrusions to gain access to the blood.  It has been shown that circulating 
DCs home to the thymus by employing a multi-step adhesion cascade.  
Blockade of α4 integrin abrogated homing of DCs into the thymus83 (Fig. 12c) 
but did not alter the frequency of TE-DCs as evaluated by FACS analysis 
(Fig. 24a).   
In order to assume a bi-compartmental phenotype, DCs have to penetrate 
through the endothelial barrier, including the underlying basement membrane.  
It is possible that the same molecules that are utilized for transendothelial 
migration also play a crucial role in this process.  In particular, PECAM-1 and 
CD99 have been shown to promote transendothelial migration of 
monocytes197.  As there are only limited reagents available to address the role 
of CD99 in adhesion and migration in mice we focused on the potential role of 
PECAM-1.  PECAM-1 consists of six Ig-like extracellular domains that 
promote transendothelial migration198,199 and thus, blocking of these domains 
with blocking mAb abrogates  diapedesis.  Howecer, pretreatment of mice 
with non-depleting anti PECAM-1 blocking mAb had no effect on the TE-DCs 
(Fig. 24b), suggesting that the formation of TE-DCs is PECAM-1 
independent.   
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Fig. 24.  Bi-compartmental localization of thymic DCs is dependent on CX3CR1 but 
not α 4 integrin, PECAM-1 or α L integrin.  One hour before administration of anti 
CD11c-PE, animals were either injected with non-depleting anti α 4 (a), anti 
PECAM-1 (b) or anti α L blocking mAb (b) or left untreated (NT, a, b).  PE+ DCs 
were assessed by flow cytometry.  (c) Age and sex matched wild type and 
CX3CR1 deficient animals were injected with anti CD11c-PE and analyzed for PE+ 
thymic DCs by FACS.  (d) Cell counts of DCs in whole thymus lobes of sex and 
age matched wild type and CX3CR1 deficient mice.  Data was pooled from two 
independent experiments, n = nine mice per group.  P values were calculated 
using two-tailed, unpaired Student’s t-test, n.s. non significant, ***P < 0.0002.  
 
We have established here that TE-DCs are enriched in CD11c+CD8α–CD11b+ 
DCs (Fig. 21g).  This subset also expressed the chemokine receptor CX3CR1 
which is also expressed on patrolling monocytes that “crawl” on resting 
endothelium159.  Importantly, patrolling CX3CR1highCCR2– monocytes per se 
do not contribute to the pool of transendothelial DCs as they do not express 
CD11c159 and thus cannot be labeled with anti CD11c-PE mAb.  Crawling of 
monocytes on the endothelium is known to depend on LFA-1 (αLß2) and, to a 
lesser extent, on CX3CR1159.  To address the potential role of LFA-1 in the 
formation of TE-DCs, we injected an αL integrin blocking mAb or isotype 
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control mAb and enumerated TE-DCs.  Blockade of LFA-1 did not interfere 
with TE-DCs (Fig. 24b).   
Given that CX3CR1 contributes to the crawling behavior of monocytes and 
CX3CR1+ lamina propria DCs can directly sample the small intestine by 
protruding dendrites into the lumen200, we tested the role of this chemokine 
receptor.  Age and sex matched wild type or CX3CR1 deficient mice 
(Cx3cr1gfp/gfp)106 were injected with PE labeled anti CD11c mAb or isotype 
control mAb.  Flow cytometric analysis of thymic DCs showed that in the 
absence of CX3CR1, significantly fewer cells acquired the intravascular label 
(Fig. 24c).  This was not due to a developmental defect of DCs in CX3CR1 
deficient mice, as the number of DCs per thymus of wild type and deficient 
mice was virtually identical (Fig. 24d).   
This data suggests that the appearance of TE-DCs is an active process that is 
at least partially regulated by the chemokine receptor CX3CR1.  How exactly 
CX3CR1 promotes the formation of TE-DCs is not clear yet and future 
experiments will aim to further investigate the underlying mechanism.   
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Discussion 
 
In vivo imaging of the thymus 
 
The advent of time-lapse multi-photon intravital microscopy has enabled 
researchers to visualize cells deep within their native 3D environment in mice.  
Pioneer work in LN of mice has helped us to gain a better understanding of 
how immune responses are initiated and of the cross talk of lymphocytes with 
APCs133,201.  To date, a multitude of organs, such as bone marrow, brain, 
lungs, skin and many more have been successfully subjected to MP IVM in 
mice202-205.  However, the thymus has not been one of them.   
Imaging of the thymus is particularly interesting due to its specialized function 
in T cell development and selection.  Failure to develop a functional thymus, 
as seen in nude mice and in patients suffering from the DiGeorge Anomaly, is 
accompanied by a lack of T cells.  The DiGeorge Anomaly describes a 
genetic encoded disorder that causes developmental defects in organs 
derived from the third and fourth pharyngeal pouches, such as the thymus 
and the heart.  These individuals are severely immune depressed and their 
average life span does not exceed two years without treatment206-209.  
Similarly, mice that were thymectomized at birth, have reduced T cell 
numbers, are more susceptible to infections and die prematurely210.  Thus, the 
thymus is an essential organ that supplies the body with polyclonal T cells that 
are important to fight bacterial, viral, fungal and parasitic insults.  Despite its 
essential role in generating a protective T cell repertoire, only little is known 
about the dynamics of T cell development and antigen presentation within the 
thymus.   
Only the thymi of medaka have been successfully visualized in live animals to 
date211.  Medaka are translucent fish that develop ex utero.  Because of this, 
they can be subjected to IVM without the requirement for surgically accessing 
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the thymus or induction of anesthesia.  Experiments with medaka have 
provided new insights into the colonization of the thymus anlage, which 
occurs in medaka from anterior to posterior.  Furthermore, thymocyte motility 
in the embryonic medaka thymus was greatly reduced as compared to T cells 
in adult thymi211.   
The mammalian thymus has not been subjected to IVM because of the 
different anatomical and optical features of mammals as compared to 
medaka.  In mammals the thoracic thymus is located in the ribcage and in 
direct contact with lungs and heart, which makes it inaccessible for (MP) IVM.  
Even under the hypothetical assumption that it would be possible to access 
the thoracic thymus without interfering with respiration, the immobilization of 
the organ would pose a significant obstacle.  As the thymus rests on the heart 
it moves with the heartbeat.  Technically, there are imaging devices available 
that allow for synchronization of the heartbeat with the cycle time.  However, 
as the thymus also directly contacts both lungs, synchronization would have 
to be achieved with the heartbeat and respiration.  In order to provide 
consistent respiration, the lungs would have to be mechanically ventilated.  
Even if it were possible to access and sufficiently immobilize the thoracic 
thymus, it would still be difficult to visualize cells that are located in the 
medulla because the thymus is a relatively opaque tissue.  The maximal 
penetration depth by MPM is about 200 µm and the medullas of thoracic 
thymi in almost 80% of six to twelve week-old mice are located deeper within 
the organ.  One alternative approach to image the thoracic thymus is by 
subjecting ectopic, cervical thymi to MP IVM.  Cervical thymi consist of a 
single lobe, they are smaller in size, and medullary regions are located more 
superficially35.  They are not located within the ribcage; instead, they are 
spread out in the deep cervical region.  They are often found in similar 
anatomical regions as the deep cervical lymph nodes, although their number 
and exact location vary and not each mouse has one35.  Cervical thymi are 
often mistaken for deep cervical LNs as they are similar in size and 
appearance.  Because of their location deep within the cervical neck region, it 
is challenging to sufficiently expose them for MP IVM without causing 
substantial damage to the surrounding tissue.  Though cervical thymi have 
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been shown to support T cell development, their function still remains 
somewhat enigmatic35.  Further experiments, such as transplantation into 
athymic nude mice will be necessary to demonstrate whether or not they are 
equally effective in supporting T cell development as compared to thoracic 
thymus lobes.   
It is of note that explanted. mammalian thymus tissue has been successfully 
subjected to MPM.  Bousso et al used reaggregated thymic organ cultures 
and fetal thymic organ cultures in combination with MPM to visualize 
encounters between thymocytes and stromal cells183. Though this ex vivo 
system provides all cell types present in a native thymus, the thymic 
architecture is disrupted.  It can be concluded that intact cortical and 
medullary regions are indispensable for central tolerance184. Additionally, this 
system cannot provide important factors such as a constant blood flow or 
innervation that contribute to / may influence dynamics within the thymus.  
Other studies took advantage of so called acute thymic slice preparation to 
visualize thymocyte – stromal cell interaction during positive selection185,186. 
This approach enables to follow developing T cells through cortex and 
medulla. However, the disadvantage of this set up is that the preparation of 
the thymus requires a broad range of different temperatures ranging from 4°-
37°C that may influence cellular behavior. Also, factors like blood flow or 
innervation cannot be provided in this in vitro system.   
We have demonstrated here for the first time that it is possible to image the 
thymus of mice in vivo.  Because of the constraints of the location of the 
thoracic thymus, we took advantage of a transplantation model by which 
individual thoracic thymus lobes of embryonic donor mice were transplanted 
under the kidney capsule of young recipient mice.  We have shown that 
transplanted thymi closely mirror their endogenous counterparts in terms of 
compartmentalization into cortex and medulla, vascularization, T cell 
development, DC subset composition and DC homing.  Importantly, we found 
that medullas were located more superficially in transplanted thymi than 
endogenous thymi, which was most likely due to the overall reduced size of 
the transplant.  This reduction in size can likely be attributed to the location of 
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the transplant.  While the kidney provides a nourishing environment with 
ample opportunities for revascularization, there is a space restriction due to 
the capsule.  Thus, it seems likely that the grafted, revascularized thymus 
lobe provides all features necessary to unfold to its full potential but is 
prevented by the spatial limitation dictated by the limited space between 
kidney and its capsule.   
In order to successfully subject transplanted thymus lobes to MP IVM 
microscopy, the organ has to be completely immobilized.  Owing to the 
acquisition process, even subtle movements will introduce motion artifacts 
that are nearly impossible to correct for post acquisition with current imaging 
software.  In order to generate a 4D movie, a predetermined imaging volume 
is recorded by acquiring a series of optical section along the z-axis at a given 
time interval over a given period of time.  Generally, we acquire 8-12 optical 
sections that are vertically spaced no more than 3 µm apart at a time interval 
of 15 or 20 seconds for 241 or 181 cycles, respectively.  This results in a one-
hour acquisition.  Thus, a 3D snapshot is made every 15 (or 20) seconds.  We 
have no information about the events between each acquisition (cycle).  In a 
well-immobilized organ, it is fairly straightforward to reassemble most cell 
tracks based on the information that has been gathered.  However, motion 
artifacts introduce a new level of complexity.  Slight, consistent motion 
artifacts such drifting within the xy-plane can be corrected using image 
processing software.  Drifts along the z-axis, as well as inconsistent or rapid 
drifts are difficult to correct for and thus can render the collected movies 
uninterpretable.  In other words, it is of highest priority to sufficiently 
immobilize the organ for MP IVM.  One option to reduce drifts would be to 
expose and separate the kidney as much as possible from the torso of the 
animal.  Unfortunately, this is problematic, as it would constrict the blood flow 
to and especially from the kidney, causing hypoxia of the tissue which 
ultimately influences cell motility and causes stasis.  We found that the most 
efficient way for immobilization was to glue the organ to its platform with 
tissue glue and to additionally place a small needle above and below the 
transplant, distally to the thymus to pin the kidney down.  Pinning down the 
kidney is likely to obstruct the local microcirculation; however, the 
Discussion 
87 
microcirculation to the transplant remains unaffected as long as the distance 
between the needles and the transplant is sufficient.   
Lastly, to visualize cellular behavior within the thymus, it is crucial that the 
cells of interest are fluorescently tagged. However, developing thymocytes are 
highly proliferative cells and as a result, ex vivo labeling of thymocytes with 
fluorescent cell trackers such as CFSE followed by adoptive transfer is not 
feasible.  Cell trackers are diluted when a cell divides.  Labeled thymocytes 
that are highly proliferative would rapidly dilute out the label to a degree where 
it is below the detection limit of the microscope.  Another problem with 
adoptively transferred thymocytes is their poor ability to home to the thymus 
from the blood.  While adoptively transferred HSPC, LSK, CLP and CLP-2 can 
give rise to T cells in the thymus, only CLP-2 cells are equipped with the 
necessary machinery to do so41,212-214, and more committed thymocyte 
precursors have lost their ability to enter the thymus from the blood and 
instead express trafficking molecules that are geared for interstitial migration 
within the organ40.  DN3 cells and their progeny that have down regulated the 
surface expression of CD44 retain poor capacity to home to the thymus when 
given intravenously40,41,215.  We therefore worked with genetically tagged 
thymocytes that express either GFP or dsRed under the CD4 promoter to 
circumvent these shortcomings.  All T cells express the fluorescent protein in 
these mice.   
Using the herein described approaches we were able to describe the dynamic 
behavior of thymocytes and DCs and their interactions with each other in 
thymi of living mice.   
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Thymocyte behavior 
 
We have shown here that TCR tg thymocytes migrate at higher velocities in 
the medulla as compared to the cortex in the absence of cognate Ag.  
Medullary thymocytes also scan a smaller volume and appear to migrate in a 
more confined fashion.  These results are in agreement with data derived 
from explanted thymi186.   
Why do medullary thymocytes move faster than cortical thymocytes, yet are 
more confined in their migration?  The answer is likely to be found in the 
different selection processes that take place in cortex and medulla, 
respectively.  TCR tg thymocytes prematurely express a fully rearranged 
TCR189, eliminating the need for β-selection.  Positive selection generates a 
self-restricted T cell pool by selecting for TCR specificities that can interact 
with self-peptide presented on MHC molecules40.  It is known that positive 
selection is greatly abbreviated in time, and TCR tg T cells will receive a 
positively selecting signal faster, as the TCR of TCR tg mice has already been 
selected for passing positive selection (cloned from a peripheral T cell).  
Consequently, this scenario would eliminate the need to scan the cortex 
thoroughly for sAg, as they possess the ability to scan a greater volume 
(higher motility coefficient).  For that reason, TCR tg thymocytes have been 
used to study positively selected T cells while wt thymocytes served as 
negative controls due to the high percentage of cells that get deleted during 
this process48.  It has been shown that positively selected thymocytes migrate 
more directly as compared to pre-selection thymocytes48.  After passing 
positive selection, TCR tg thymocytes enter the medulla where they test their 
TCR in the course of negative selection40.  This time the scenario is markedly 
different, as wt animals do not express cognate ligands for the tg TCR and 
thus cannot shorten the quest of tg thymocytes.  We suggest that higher 
velocities and low motility coefficients, which indicate that these cells patrol 
through a smaller volume, are reflective of the scanning behavior of TCR tg 
thymocytes in medulla versus cortex.  Specifically, high velocities may enable 
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tg thymocytes to interact with a maximal number of cells and the confined 
migration could be indicative of preferential scanning of APCs in the vicinity.   
Ag-specific thymocytes dramatically change their migratory behavior in the 
presence of cognate Ag.  We have shown here in vivo that specific OT-I TCR 
tg thymocytes reduce their speed by a third and further restrict the volume 
that they scan upon adoptive transfer of peptide pulsed DCs.  This altered 
behavior was not observed in control cells that were present in the same 
imaging volume, excluding any bystander effects.  A similar change in OT-I 
cell motility has been described in an ex vivo study that utilized the RIP-
mOVA system186.  In RIP-mOVA mice, mTECs express ovalbumin due to the 
transcriptional regulator Aire and it has been shown that thymic DCs can gain 
access to the protein and present it to developing T cells75.  Therefore, our 
approach differs from the RIP-mOVA system in the APC that is presenting the 
cognate Ag and, presumably, in the Ag dose that is being presented.  Despite 
these differences, there is a surprising consistency among OT-I T cell motility 
in the presence and absence of Ag between these studies.  The measured 
mean velocities per track, which tend to be an over-estimate of the actual 
velocity of the cells, are almost identical186.   
We have shown in our study for the first time that long-lasting cognate 
interactions are formed during negative selection in vivo.  18% of Ag specific 
thymocytes interacted with DCs for the entire imaging period of 60 minutes 
and 24% for at least 30 minutes.  Thus, we have shown for the first time that 
these interactions can last long enough to form an immunological synapse, 
which has been shown to take 30 minutes to form in peripheral tissues195.  It 
is noteworthy that immunological synapses during positive and negative 
selection differ in their architecture and stability as compared to 
immunological synapses that are established during T cell activation in 
peripheral tissues.  Also synapses in positive versus negative selection differ, 
while only short-lived multifocal synapses are built during positive selection, 
negative selection includes the formation of more stable synapses that can 
last up to seven hours in vitro216,217.   
Discussion 
90 
The interaction times measured in our study greatly exceeded those that had 
been measured in the ex vivo RIP-mOVA model between OT-I TCR tg 
thymocytes and DCs186.  This difference is most likely caused by the different 
source of the antigen.  In RIP-mOVA mice, mTECs express the cognate 
protein and DCs gain access to it by Ag transfer75, thus, it is likely that specific 
thymocytes preferentially interact with mTECs rather than DCs in RIP-mOVA 
mice.  Indeed, it was shown in that OT-I T cells migrated in confinement 
zones in RIP-mOVA mice, meaning that OT-I TCR tg thymocytes stayed in 
the vicinity of DCs but didn’t interact with them186.  These confinement zones 
could reflect the interaction of specific T cells with Ag expressing mTECs, 
which were not visualized in this study.  Assuming that OT-I T cells 
preferentially interact with mTECs, one could speculate that the relatively 
short interaction times in the presence of cognate Ag are non-specific 
interactions rather than Ag-driven ones.  The interaction time of OT-I T cells in 
the presence or absence of Ag (mean interaction time 1.2 min versus 1.9 min) 
differed by only a third186, while we observed a much greater difference for 
mean interaction times for cognate and non-cognate T cell – DC interactions 
(18.7 min versus 3.7 min).  It is of note that by adoptively transferring Ag 
pulsed DCs, we specifically targeted the Ag to these DCs.  Furthermore the 
amount of Ag that is presented by pulsed transferred DCs is likely to differ 
from the amount presented by DCs in RIP-mOVA mice, which have to gain 
access to it from mTECs via Ag transfer75.  It is possible that the interaction 
times that were measured between OT-I TCR tg thymocytes with and DCs in 
RIP-mOVA mice were non-specific as OT-I T cell motility was reduced by a 
third in RIP-mOVA mice as compared to wt mice but the measured interaction 
times were increased by a third186.  The inversed correlation between 
thymocyte speed and interaction time could indicate that the observed DC – T 
cell interactions are indeed non-specific and consequently the increase of 
interaction time could be explained by the reduction of migration speed of the 
thymocytes.   
We also found in our study that not all Ag specific thymocytes engaged in 
prolonged interactions, which was expected, as thymocytes are a 
heterogeneous population with regard to their developmental stage.  
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Thymocytes in the medulla and CMJ mainly consist of DP, semi-mature and 
mature SP thymocytes.  SP semi-mature but not mature SP cells are still 
susceptible to negative selection57.  Thus, the developmental stage of the 
thymocytes influences their susceptibility to negative selection and could 
explain the fact that not all tg thymocytes engage in prolonged interactions.   
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Thymic DCs 
 
Thymic DCs are a heterogeneous population.  They can either be subdivided 
according to the expression of surface markers or their place of origin.  
Approximately 10% of all thymic DCs have not developed in situ but homed to 
the organ from the periphery by employing a multi-step adhesion 
cascade80,83,84,118,119.  While all splenic DC subsets from Flt3L injected 
animals have a similar capacity to home to the thymus from the blood, pDCs 
and CD8α+11b– (but not CD8α–11b+) cDCs are preferentially retained or have 
a higher survival rate in the organ.  The DC subset contribution of homed DCs 
closely resembles the endogenous subset distribution at 18 hours post DC 
transfer.  In line with this, it has been shown that thymic pDCs and CD8α– 
DCs can enter the thymus from the periphery while CD8α+11b– DCs are 
predominantly thymus resident.  About 30% of resident CD8α+11b– cDCs and 
pDCs in the thymus carry IgH rearrangement in the TCRα locus, indicating 
that they have developed intrathymically from DN cells81.  This suggests that 
thymic pDCs can develop in situ as well as entering the thymus from the 
periphery.  It is currently unknown whether thymic DCs can leave the organ in 
the steady-state.  We have shown in adoptive transfer experiments that all DC 
subsets home to the thymus equally well, but are retained differentially.  
Adoptive transfer experiments rely on the injection of non-physiologically high 
numbers of DCs, thus, it is not clear whether thymic DCs can emigrate under 
the steady state as well.  This is a particularly interesting point as thymic 
pDCs can arise intra- and extrathymically.  It is possible that thymus-borne 
pDCs leave the organ, circulate through the blood and re-enter the thymus.   
Homed DCs display a motile behavior upon entering the thymus.  As it was 
shown that they can carry Ag as their cargo and induce central tolerance 
against it83,84, it is conceivable that this behavior serves to optimize the display 
of the delivered Ag within the thymus.  In contrast, thymus resident DCs are 
more sessile and have a more dendritic, spread-out shape.  We found that 
they were often in tight contact with small blood vessels, which was not 
observed for homed DCs.  It is of note that two hours post transfer, homed 
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DCs were frequently found “stuck” in the lumen of thymic blood vessels.  We 
speculate that resident DCs can breach the endothelial layer and access the 
blood given their association with vascular structures.  Indeed, we found that 
thymic DCs can be stained intravascularly, demonstrating that they are 
exposed to the blood.  The staining intensity and pattern was consistent with a 
transendothelial positioning rather than fully intravascular localization.  We 
named these cells TE-DCs.  They are defined by their location within the 
thymic stroma but are at least partially exposed to the lumen of a blood 
vessel.  We also provided evidence that thymus resident but not homed DCs 
are specialized in adopting a transendothelial phenotype.   
This previously under-appreciated positioning of some thymus resident DC 
poses an interesting question: why do thymic DCs breach the endothelial 
layer to access the blood?  The most intriguing scenario is that they do so to 
sample the blood for self-peptides and proteins in order to make them 
available for T cell selection.  Assuming that this is the case, homed and 
resident DCs differ not only by their place of origin but may also have different 
specializations.  While homed DCs can deliver Ag from peripheral tissues to 
the thymus, a subset of resident DCs is strategically positioned to access the 
blood from the thymus to sample for circulating antigenic material.  Therefore 
both subsets would play an important role in making peripheral Ag available 
for T cell selection; however, they do so by employing different mechanisms.  
Sampling blood-borne Ag for presentation could be crucial for inducing 
tolerance to abundant serum proteins that are too large to diffuse into the 
thymus and are not expressed in the thymus per se.   
Another possible explanation for the appearance of transendothelial DCs is 
that these cells may be caught in the process of migrating to and from the 
thymus.  Homed DCs employ a multi-step adhesion cascade and blockade of 
α4 integrins abrogated DC homing to the thymus but did not interfere with the 
emergence of transendothelial DCs.  While it is not known whether α4 
integrins also play a role in the possible emigration of thymic DCs, this 
experiment at least excludes the possibility that TE-DCs are in the process of 
homing to the thymus.   
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The role of CX3CR1 in transendothelial DCs 
 
This apparent sampling behavior of TE-DCs led us to investigate the possible 
mechanisms for extending these transendothelial protrusions.  As these 
protrusions must breach the endothelial layer, likely candidates are molecules 
that have an established role in transendothelial migration.  We therefore 
investigated the role of PECAM-1 but found that blockade of the extracellular 
Ig like domains that are indispensable for diapedesis198,199 did not affect the 
formation of TE-DCs.  It has been shown that CX3CR1+ DCs in the lamina 
propria can sample the lumen of the gut and that this process is dependent on 
the expression of CX3CR1200.  In thymus and LN, the expression of CX3CR1 
coincides with CD8α–11b+ DC subset.  This subset is the main constituent of 
transendothelial DCs and expression of CX3CR1 is required for the 
appearance of these cells.  CX3CR1 deficient animals did not show any 
defects concerning DC number or location as compared to wt animals.  The 
ligand for CX3CR1, fractalkine, is expressed by resting endothelium and can 
either be secreted or expressed as a transmembrane molecule90.  Resident 
CD11b+11c–Ly6C–CX3CR1+ monocytes have been shown to display a 
crawling behavior and to patrol the vasculature.  This process was largely 
mediated through binding to LFA-1 (αLß2)159.  It is noteworthy that 
transendothelial DCs are distinct from patrolling monocytes as judged by the 
differential expression of CD11c and CD11b159.  Likewise, blockade of LFA-1 
also had no effect on the formation of TE-DCs.   
How can CX3CR1 mediate the formation of transendothelial protrusions?  In 
the lamina propria, CX3CR1 dependent protrusions are extended into the 
lumen by adherence to epithelial cells that express fractalkine159.  This 
chemokine can be expressed on resting endothelium, but the presence of 
fractalkine in the thymus or thymic microvessels has not been addressed yet.  
It is of note that thymic DCs failed to migrate in response to fractalkine in a 
chemotaxis assay82.  Interestingly, a second chemokine has been identified 
recently as a ligand for CX3CR1 – eotaxin-3 (CCL26)218.  Eotaxin-3 is 
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expressed by vascular endothelial cells, and has been shown to promote 
transendothelial migration of eosinophils219,220.  To this end it has not been 
addressed whether eotaxin-3 is expressed in the thymus.  It is possible that 
CX3CR1 – eotaxin-3 interactions promote the formation of transendothelial 
protrusions.   
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Concluding remarks 
 
The thymus is a particularly interesting organ as it provides the necessary 
environment for T cell development and selection.  There is substantial 
evidence that positive selection relies on the presentation of self-peptide that 
has been generated in the thymus.  In contrast, antigenic material for 
tolerance induction during negative selection is either expressed in the 
thymus per se or derived from the peripheral tissues.  In order to present 
peripheral Ag in the thymus, it has to gain access to the organ.  This can 
either be achieved by delivery of Ag by thymus-bound DCs, or by uptake of 
circulating Ag from the blood by thymic APCs. We have demonstrated here 
for the first time in vivo that delivery of cognate Ag to the thymus dramatically 
affects the motile behavior of specific, but not non-specific thymocytes.  
Homed, thymic DCs engaged in long-lived, Ag-dependent interactions with 
thymocytes.  We have further shown that thymus resident DCs could gain 
access to the blood.  We hypothesize that this process is geared toward 
gaining access to circulating antigenic material and to make it available for T 
cell selection.  Thus, it appears that DCs play an important role in T cell 
selection not only by Ag presentation, but also by “fetching” it from the 
periphery.  
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Materials and methods 
 
Mice 
C57BL/6 mice were from Charles River Laboratories and were used at 4–12 
weeks of age. OT-I and P14 mice, which carry a transgenic TCR specific for 
ovalbumin amino acids 257–264 (SIINFEKL) in H-2Kb and LCMV gp33–41 
(KAVYNFATC) in H-2Db, respectively, were from Taconic Farms.  DPE-GFP 
and T-Red mice were generated previously190 and crossed to OT-I191 and 
P14192 mice, respectively.  Transgenic mice (C57BL/6 background) 
expressing enhanced green fluorescent protein (eGFP) under the β -actin 
promoter were generated as described221.  Cx3xr1gfp/gfp mice were generated 
previously106 and purchased from the Jackson Laboratory.  All experiments 
were in accordance with National Institutes of Health guidelines and were 
approved by the Committees on Animal Care and Use of both Harvard 
Medical School and the Immune Disease Institute. 
 
Reagents 
Fluorochrome-conjugated mAbs to mouse B220 (RA3-6B2), CD4 (GK1.5), 
CD8α (53-6.7), CD11b (M1/70), CD11c (HL3 and N418), CD25 (PC61), CD31 
(390 an MEC13.3), PDCA-1 (927 and 129C1) and Kb-SIINFEKL (25-D1.16), 
purified neutralizing mAbs to mouse P-selectin (RB40.34), CD31 (390 and 
MEC13.3) and VCAM-1 (MK2.7) were purchased from BD Biosciences, 
BioLegend, eBioscience and Bio X cell.  Chimeric, non-depleting, anti α4 
(CRL19.11) was provided by R. Palframan (Celltech, London, UK).  TRITC 
labeled and unlabeled Ulex Europaeus agglutinin I (UEA-1) was purchased 
from Vector Laboratories; unlabeled UEA-1 was conjugated to Alexa Fluor® 
647 or Alexa Fluor® 488 according to the manufacture’s manual (Invitrogen).  
Anti Cytokeratin 8 mAb secreting hybridoma (TROMA-1) was obtained from 
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the Developmental Studies Hybridoma Bank at the University of Iowa and 
PTX was from Calbiochem.  
 
BM chimeras 
1-5 × 107 CD4 and CD8 depleted BM cells from tibia and femur from donor 
animals were injected into the lateral tail vein of sublethally (550 rad) or 
lethally (myeloablative, 950 rad) irradiated C57BL/6 mice.  For mixed BM 
chimeras, OT-I TCR tg and P14 TCR tg BM was mixed at equal ratios and 
injected in irradiated C57BL/6 recipient mice (550 rad).   
 
DC isolation 
C57BL/6 mice were injected subcutaneously with 2 ×  106 to 5 ×  106 B16 
melanoma cells secreting Flt3 ligand as described222.  After 10–14 d, mice 
were killed and splenic DCs were purified by digestion in 50 µg/ml Liberase 
TM (Roche) for 20 min at 37ºC followed by density-gradient centrifugation 
over NycoPrep (Axis-Shield) according to the vendor’s manual. These 
preparations routinely contained 75–85% CD11c+ DCs. When indicated, DC 
maturation was induced by culture for 24 h in complete medium in the 
presence of 1 µg/ml of lipopolysaccharide (E. coli 0.26:B6; Sigma-Aldrich). 
Mature DC cultures typically resulted in enrichment in CD11c+ cells (90–95%) 
and in the up-regulation of classical maturation markers (CD86 and MHC 
class II) for all CD11c+ cells. 
 
Thymus transplantation 
Individual thymus lobes from E14.5 – 18.5 embryos were transplanted under 
the kidney capsule of anesthetized recipient mice.  At the day of imaging, 
transplanted thymi were gently exposed and immobilized on a Styrofoam 
platform with two 27G1/2 needles.  The exposed thymus was submerged in 
sterile saline and covered with a glass cover slip. A thermocouple was placed 
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next to the thymus to monitor local temperature, which was maintained at 37–
39ºC.   
 
In vivo labeling of thymic medullas 
Thymic medullas were labeled in vivo injection of 20 µg TRITC labeled UEA-1 
either intravenously or under the transplant bearing kidney capsule, distally to 
the graft, 18 hours before evaluation by MPM.   
Alternatively, medullas were identified by the relative accumulation of TCR tg 
× T-Red or TCR tg × DPE-GFP thymocytes.  Using Volocity or Imaris 
software, the number of TCR tg thymocytes per mm3 was calculated for 
cortex and medulla.  Medullas were characterized by a 2.5fold enrichment of 
TCR tg thymocytes as compared to cortex. 
 
Multi-photon microscopy 
MPM was performed on a Prairie system at an excitation wavelength of 850 
nm, from a tunable MaiTai Ti:sapphire laser (Spectra-Physics).  For three and 
for four-dimensional offline analysis of thymic architecture and cell migration, 
stacks of 9-11 optical x–y sections with 3 µm z spacing were acquired every 
15 s or 20 s, respectively, with physical zooming to ×1–2 through a 20×/0.95 
numerical aperture water-immersion objective lens (Olympus).  Emitted 
fluorescence and second-harmonic signals were detected through 455/70nm, 
450/80nm, 590/50 nm and 665/65 nm bandpass filters with non-descanned 
detectors to generate four-color images. Sequences of image stacks were 
transformed into volume-rendered three-dimensional volumes.  T series were 
converted into movies using Volocity (Perkin Elmer) and Imaris (Bitplane) 
software. Motility parameters such as three-dimensional instantaneous 
velocities, mean velocities per track, mean displacement plots, meandering 
indices and motility coefficients were determined by semi-automated cell 
tracking with Imaris and Volocity Software and computational analysis by 
MatLab (Mathworks), Excel (Microsoft Office) or Prism (GraphPad).   
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Peptide loading of DCs 
107 immature DCs per ml were pulsed with 1 µM SINFEKL peptide for 45 
minutes at 37ºC in PBS supplemented with 2% FCS.  DCs were washed twice 
before i.v. injections.   
For the generation of loading curves, immature DCs were incubated with the 
indicated concentration of SIINFEKL peptide for two hours, washed, and 
stained with anti CD11c and anti Kb-SIINFEKL mAbs for 15 minutes.  DC 
loading efficiency was evaluated by flow cytometry.   
 
Interaction analysis 
Interactions between T cells and DCs were defined as physical contacts 
lasting more than one min and were obtained by frame-to-frame inspection of 
4D recordings.   
 
Immunofluorescence 
For cryosections, thymi were harvested, fixed in phosphate-buffered L-lysine 
with 1% paraformaldehyde/periodate (PLP), dehydrated in 30% sucrose in 
PBS, snap-frozen in TBS tissue-freezing liquid (Triangle Biomedical Sciences) 
and stored at –80ºC.  Sections of 30 µm thickness were mounted on 
Superfrost Plus slides (Fisherbrand) and stained with fluorescent antibodies in 
a humidified chamber after Fc-receptor blockade with 1 µg/ml antibody 2.4G2 
(Bio X cell). Samples were mounted in FluorSave reagent solution (EMD-
Calbiochem) and stored at 4ºC until analysis.   
For immunofluorescence analysis of DCs, MHCII+ cells isolated by MACS 
purification and incubated on poly-L-lysine coated slides for 15 minutes at 
room temperature, non-adherent cells were removed by washing and slides 
were fixed by incubation with PLP for one hour at 4ºC.  Slides were stained as 
described. 
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Images were collected with a Bio-Rad confocal microscopy system using an 
Olympus BX50WI microscope and 10×/0.4 numerical aperture or 60×/1.2 
numerical aperture water-immersion objective lenses. Images were analyzed 
with LaserSharp2000 software (Bio-Rad Cell Science), Volocity (Perkin 
Elmer) and Imaris (Bitplane). 
 
Homing assays 
Immature or mature DCs were labeled for 15 min at 37ºC with 30 µM CFSE 
(carboxyfluorescein succinimidyl ester) or 3 µM DDAO-SE (7-hydroxy-9H-
(1,3-dichloro-9,9-dimethylacridin-2-one) succinimidyl ester; all from Molecular 
Probes) at a concentration of 107 cells / ml.  Dead cells and excess label were 
removed by centrifugation, and 1 to 5 × 107 labeled DCs were then injected in 
the tail veins of recipient mice.  In some experiments, DCs were pretreated 
with 50 µg/ml of blocking mAb for one hour at 37ºC and washed before 
simultaneous injected with control populations; for inhibition of endothelial 
adhesion molecules, 100 µg mAb was injected along with the labeled DCs.  
Mice were killed at indicated time points and single-cell suspensions were 
generated from spleens and thymi and cell samples were incubated with anti-
CD11c and analyzed on a FACS Canto (BD Biosciences). The total number of 
homed DCs was calculated by multiplication of the fraction of CFSE+ (or 
DDAO-SE+) CD11c+ events by the total cellularity of the target organ. 
 
Intravascular labeling of leukocytes 
Leukocytes were labeled intravascularly by i.v. injection of PE conjugated 
monoclonal Ab to CD45 or CD11c.  Animals were sacrificed two minutes post 
injection by CO2 asphyxiation.   
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Statistical analysis 
Data are presented as mean ± s.e.m. for normally distributed data sets. 
Statistical significance was assessed by two-tailed, unpaired Student’s t-test 
for comparison of two groups or by one-way analysis of variance (ANOVA) 
followed by the Student Newman Keuls post-test for more than two groups. 
Differences with P values of less than 0.05 were considered significant.  Non-
normally distributed data were presented as medians and compared with the 
Mann–Whitney U-test (two groups) or the Kruskal–Wallis test followed by 
Dunn’s test to compare multiple samples.   
 
Abbreviations 
103 
Abbreviations 
3D three dimensional 
3DIV three dimensional instantaneous velocity 
4D four dimensional 
Ab antibody 
Ag antigen 
ANOVA analysis of variance 
APC antigen presenting cell 
APECED autoimmune polyendocrinopthy-candidiases-
ectodermaldystrophy 
AU arbitrary unit 
BCR B cell receptor 
BM bone marrow 
CDA cystidine deaminase 
cDCs conventional dendritic cell 
CFSE carboxyfluorescein succinimidyl ester 
Cld claudin 
CLP common lymphoid progenitor 
CMJ cortico-medullary junction 
cTEC cortical thymic epithelial cell 
Cnx connexin 
DC dendritic cell 
Dll delta like ligand 
DN double negative 
DP double positive 
DZ denritische Zelle 
FACS fluorescence activated cell sorting 
FITC fluorescein isothiocyanate 
Foxn1 forkhead box N1  
FSC forward scatter 
PECAM-1 platelet-endothelial cell adhesion molecule-1 
GFP green fluorescent protein 
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GPCR G protein coupled receptor 
HSA heat stable antigen (CD24) 
HSC hematopoietic stem cell 
HSPC hematopoietic stem and progenitor cell 
i.v. intravenous 
Ii invariant chain 
IVM intravital videomicroscopy 
kDa kilo dalton 
KLF2 Kruppel like factor 2 
LC langerhans cell 
LN lymph node 
LRR leucine rich repeat 
LSK lineage– Sca-1+ c-Kit+ cells 
MFI mean fluorescence intensity 
MHC major histocompatibility complex molecule 
MHC-I major histocompatibility complex molecule class I 
MHC-II major histocompatibility complex molecule class II 
mOVA membrane bound ovalbumin 
MΦ macrophage 
MP multi photon 
MP IVM multi photon intravital videomicroscopy 
MPM multi photon microscopy 
mTEC medullary thymic epithelial cell 
MW molecular weight 
NC neural crest 
NK natural killer 
n.s. non significant 
NT not treated 
OVA ovalbumin 
PA-GFP photoactivatable green fluorescent protein 
pDC plasmacytoid dendritic cell 
PE phycoerythrin 
PGE promiscuous gene expression 
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PLT primary lymphoid organ 
PSGL-1 P-selectin glycoprotein ligand 1 
PTX Bordetella pertussis toxin 
PVS perivascular space 
RIP rat insulin promoter 
RTOC reaggregated thymic organ culture 
S1P sphingosine-1-phosphate 
S1P1 sphingosine-1-phosphate receptor 
sAg self antigen, Selbstantigen 
s.e.m. standard error of the mean 
SCA subcapsular area 
SLO secondary lymphoid organ 
SP single positive 
SSC side scatter 
TCR T cell receptor 
TE transendothelial 
TD thoracic duct 
tg transgenic 
Treg regulatory T cell 
TRITC tetramethylrhodamine isothiocyanate 
UEA-1 Ulex Europeaus agglutinin 1 
VCAM-1 vascular cell adhesion molecule 1 
VLA4 very late antigen 4 
VLR variable lymphocyte receptor 
wt wild type 
YFP yellow fluorescent protein 
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